Multiple testing procedures for complex structured hypotheses and directional decisions by Grandhi, Anjana
New Jersey Institute of Technology
Digital Commons @ NJIT
Dissertations Theses and Dissertations
Spring 2015
Multiple testing procedures for complex structured
hypotheses and directional decisions
Anjana Grandhi
New Jersey Institute of Technology
Follow this and additional works at: https://digitalcommons.njit.edu/dissertations
Part of the Mathematics Commons
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Digital Commons @ NJIT. It has been accepted for
inclusion in Dissertations by an authorized administrator of Digital Commons @ NJIT. For more information, please contact
digitalcommons@njit.edu.
Recommended Citation
Grandhi, Anjana, "Multiple testing procedures for complex structured hypotheses and directional decisions" (2015). Dissertations.
119.
https://digitalcommons.njit.edu/dissertations/119
 
Copyright Warning & Restrictions 
 
 
The copyright law of the United States (Title 17, United 
States Code) governs the making of photocopies or other 
reproductions of copyrighted material. 
 
Under certain conditions specified in the law, libraries and 
archives are authorized to furnish a photocopy or other 
reproduction. One of these specified conditions is that the 
photocopy or reproduction is not to be “used for any 
purpose other than private study, scholarship, or research.” 
If a, user makes a request for, or later uses, a photocopy or 
reproduction for purposes in excess of “fair use” that user 
may be liable for copyright infringement, 
 
This institution reserves the right to refuse to accept a 
copying order if, in its judgment, fulfillment of the order 
would involve violation of copyright law. 
 
Please Note:  The author retains the copyright while the 
New Jersey Institute of Technology reserves the right to 
distribute this thesis or dissertation 
 
 
Printing note: If you do not wish to print this page, then select  
“Pages from: first page # to: last page #”  on the print dialog screen 
 
  
 
 
 
 
 
 
 
 
 
 
 
The Van Houten library has removed some of the 
personal information and all signatures from the 
approval page and biographical sketches of theses 
and dissertations in order to protect the identity of 
NJIT graduates and faculty.  
 
ABSTRACT
MULTIPLE TESTING PROCEDURES FOR COMPLEX
STRUCTURED HYPOTHESES AND DIRECTIONAL DECISIONS
by
Anjana Grandhi
Several multiple testing procedures are developed based on the inherent structure
of the tested hypotheses and specific needs of data analysis. Incorporating the
inherent structure of the hypotheses results in development of more powerful and
situation-specific multiple testing procedures than existing ones. The focus of this
dissertation is on developing multiple testing procedures that utilize the information
on this structure of the hypotheses and aims at answering research questions while
controlling appropriate error rates.
In the first part of the thesis, a mixed directional false discovery rate (mdFDR)
controlling procedure is developed in the context of uterine fibroid gene expression
data (Davis et al., 2013). The main question of interest that arises in this research
is to discover genes associated with various stages of tumor progression, such as
tumor onset, growth and development of tumors and large size tumors. To answer
such questions, a three-step testing strategy is introduced and a general procedure
is proposed that can be used with any mixed directional familywise error rate
(mdFWER) controlling procedure for each gene, while controlling the mdFDR as the
overall error rate. The procedure is proved to control mdFDR when the underlying
test statistics are independent across the genes. A specific methodology, based on the
Dunnett procedure, is developed and applied to the uterine fibroid gene expression
data of Davis et al. (2013). Several important genes and pathways are identified that
play important role in fibroid formation and growth.
In the second part, the problem of simultaneously testing many two-sided
hypotheses is considered when rejections of null hypotheses are accompanied by
claims on the direction of the alternative. The fundamental goal is to construct
methods that control the mdFWER, which is the probability of making a Type
I or Type III (directional) error. In particular, attention is focused on cases
where the hypotheses are ordered as H1, . . . , Hn, so that Hi+1 is tested only
if H1, . . . , Hi have all been previously rejected. This research proves that the
conventional fixed sequence procedure, which tests each hypothesis at level α, when
augmented with directional decisions, can control mdFWER under independence and
positive regression dependence of the test statistics. Another more conservative
directional procedure is also developed that strongly controls mdFWER under
arbitrary dependence of test statistics.
Finally, in the third part, multiple testing procedures are developed for making
real-time decisions while testing a sequence of a-priori ordered hypotheses. In large
scale multiple testing problems in applications such as stream data, statistical process
control, etc., the underlying process is regularly monitored and it is desired to control
False Discovery Rate (FDR) while making real time decisions about the process being
out of control or not. The existing stepwise FDR controlling procedures, such as
the Benjamini-Hochberg procedure, are not applicable here because of the implicit
assumption that all the p-values are available for applying the testing procedure. In
this part of the thesis, powerful Fallback-type procedures are developed under various
dependencies for controlling FDR that award the critical constants on rejection of
a hypothesis. These procedures overcome the drawback of the conventional FDR
controlling procedures by making real-time decisions based on partial information
available when a hypothesis is tested and allowing testing of each a-priori ordered
hypothesis. Simulation studies demonstrate the effectiveness of these procedures in
terms of FDR control and average power.
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The best thing about being a statistician is that you get to
play in everybody’s backyard. The combination of some
data and an aching desire for an answer does not ensure
that a reasonable answer can be extracted from a given
body of data. Today, [software] is at least as important
as the ‘hardware’ of tubes, transistors, wires, tapes and
the like. Far better an approximate answer to the right
question, which is often vague, than the exact answer to
the wrong question, which can always be made precise.
John Wilder Tukey
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CHAPTER 1
INTRODUCTION
1.1 Introduction
Scientific experiments are often subject to rigorous statistical analyses that almost
always involve simultaneous evaluation of more than one research question. Multiplicity
or the occurrence of multiple errors becomes an inherent problem in such analyses.
As a consequence, the findings of an experiment can be misleading and the effect
of multiplicity needs to be addressed to draw valid scientific conclusions. Multiple
testing procedures (MTPs) adjust statistical inference by accounting for multiplicity
and avoid declaring an effect when there is none. Multiple testing methodology plays
an important role in analysis of data from a varied range of fields like bioinformatics,
clinical trials, regression analysis and modeling to mention a few. The importance
of MTPs in the analysis of large scale experiments like microarray experiments,
genome-wide association studies, fMRI experiments needs special mention. Several
interesting and powerful MTPs have been developed for handling different situations
in these kinds of data while controlling appropriate error rates.
In single hypothesis testing, the error measure that is controlled is the
probability of making a Type I error. But in multiple testing, there are several
possible measures of overall Type I error rate. A popular and widely used error rate
is the familywise error rate (FWER), which is the probability of making at least one
false rejection. It is to be noted that the control of FWER is appropriate when the
number of hypotheses tested simultaneously is small or moderate, but it proves to be
too conservative when large number of hypotheses are tested simultaneously, which is
typically the case in large scale experiments like microarray or fMRI. Benjamini and
Hochberg (1995) introduced false discovery rate (FDR) as an appropriate measure to
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control while simultaneously testing a large number of hypotheses. FDR is defined
as the expected proportion of false rejections among all rejections. FDR allows more
hypotheses to be rejected while controlling the proportion of false rejections, thus,
opening the way for development of more powerful procedures than those that use
FWER as an error measure to control. For a review of multiple testing procedures
controlling the FWER, please refer to Dmitrienko et al. (2009). For a review of FDR
controlling procedures, refer to Benjamini (2010).
In multiple testing, the hypotheses to be tested are often found to possess
some complex structure. This structure can be due to the relative importance of the
hypotheses as in dose response studies where the hypotheses corresponding to higher
doses are tested prior to those corresponding to a lower dose or due to the formulation
of complex stagewise testing in large scale hypotheses testing or due to the natural
sequence of occurrence of the hypotheses in real time as in the stream data analysis.
Several researchers exploit this inherent structure to develop powerful procedures
appropriate to the testing problem. In the FWER framework, the Fixed Sequence
procedure [Maurer et al. (1995); Westfall and Krishen (2001); Wiens (2003); Wiens
and Dmitrienko (2005)] is introduced for testing a sequence of hypotheses, ordered in
advance based on some prior knowledge, while controlling FWER. Recently Qiu et al.
(2014) developed more powerful procedures for testing a fixed sequence of hypotheses
while controlling FWER. In the FDR framework, Farcomeni and Finos (2013) and
Lynch et al. (2014) introduced procedures for controlling FDR while testing a large
number of hypotheses that have an inherent structure.
Often, in multiple testing of two-sided hypotheses, it is of interest to make
directional decisions once a null hypothesis is rejected. It is important to control
Directional errors or Type III errors in addition to Type I errors in such testing.
Control of Directional errors in multiple testing set-up is a very challenging problem.
A few researchers to discuss the control of directional errors are Shaffer (1980), Finner
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(1994) in FWER set-up, Benjamini and Yekutieli (2005), Guo et al. (2010) in FDR
set-up.
In this dissertation, we consider multiple testing problems where the hypotheses
have some complex structure and sometimes require directional decisions to be made.
In many applications of multiple testing such as genomic research, clinical trials,
stream data analysis, statistical process control, the hypotheses have such complex
inherent structure. This structure may arise from prior knowledge or can be formed
by reformulating the underlying problem as in Kropf and La¨uter (2002), Kropf et al.
(2004), Westfall et al. (2004), Hommel and Kropf (2005), Finos and Farcomeni
(2011), Farcomeni and Finos (2013), Lynch et al. (2014) where a fixed sequence
structure can be formed among the hypotheses by specifying the testing order of the
hypotheses using a data-driven approach. The problem of controlling directional
errors may arise in time-course/dose-response experiments or in identifying gene
expression patterns/profiles over the ordered categories as in Guo et al. (2010) and
Sun and Wei (2011).
1.2 Basic Concepts of Multiple Hypothesis Testing
Consider the problem of simultaneous testing of m null hypotheses Hi : θi = θi0, i =
1, 2, ...,m against the corresponding alternative hypotheses denoted by H
′
i : θi 6= θi0,
based on the corresponding p-values P1, P2, ..., Pm. Let, m0 denote the number of
true null hypotheses and m1 = m −m0 denote the number of false null hypotheses.
The following is the list of the different kinds of errors that can occur while testing a
hypothesis:
• A Type I error occurs when a true null hypothesis is rejected.
• A Type II error occurs when a false null hypothesis is not rejected.
• A Type III error or Directional error occurs if, on rejection of a false null
hypothesis, a wrong assignment of direction is made, i.e., declare that θi < θi0
when in reality θi > θi0 or declare that θi > θi0 when in reality θi < θi0.
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In any MTP, each hypothesis is either rejected or not rejected. Table 1.1
summarizes the notation for all possible outcomes while simultaneously testing m
hypotheses. V denotes the number of falsely rejected hypotheses or Type I errors, S
denotes the number of correct rejections and R denotes the total number of hypotheses
rejected. In any testing situation, m, is fixed and known, and m0, the number of true
null hypotheses and m1, the number of false null hypotheses are fixed but unknown.
All of V , S and R are random but only R is observable. Let D denote the number of
Type III errors in an MTP. In the rest of the thesis we denote by I0, the set of indices
Table 1.1 Summary and Notation of Outcomes in a Multiple Testing Procedure
while Simultaneously Testing m Hypotheses.
Number of Number of
Hypotheses Hypotheses Total
Not Rejected Rejected
True Null Hypotheses m0 − V V m0
False Null Hypotheses m1 − S S m1
Total m−R R m
of true null hypotheses and I1 denotes the set of indices of false null hypotheses with
|I0| = m0 and |I1| = m1.
1.2.1 Error Measures
In multiple testing, it is important to choose an overall error rate to measure and
control Type I errors. A few commonly used Type I error measures are described
below:
4
The familywise error rate (FWER) is the probability of making at least one
Type I error and is given by,
FWER = Pr(V > 0).
The false discovery rate (FDR) is defined as the expected proportion of falsely rejected
hypotheses among all rejected hypotheses and is given by,
FDR = E
(
V
max{R, 1}
)
.
FWER and FDR are related by the following inequality with equality when m0 = m,
FDR ≤ FWER.
In situations where directional decisions need to be made, controlling only Type
I error measure is not sufficient and it is necessary to control Type III errors as well.
A few error measures are defined in the literature, based on a combination of Type I
and Type III errors.
The mixed directional familywise error rate (mdFWER) is defined as the
probability of making at least one Type I error or Type III error.
mdFWER = Pr(V +D > 0). (1.1)
The mixed directional false discovery rate(mdFDR) is defined as the expected
proportion of Type I and Type III errors among all rejections.
mdFDR = E
(
V +D
max{R, 1}
)
. (1.2)
A few other important error measures are as follows: Storey (2002, 2003) introduced
the positive false discovery rate (pFDR), which is defined as, pFDR = E(V/R|R > 0).
Lehmann and Romano (2005) introduced generalized FWER (k-FWER) which is the
5
probability of making k or more false rejections for 1 ≤ k ≤ m, k-FWER = Pr(V >
k). Sarkar (2008) introduced an analogous version of k-FWER for the large scale
testing set-up, the generalized FDR (k-FDR), which is the expected proportion of k
or more false rejections among all rejections, k-FDR = E
(
V I(V≥k)
max{R,1}
)
. False discovery
proportion (FDP) is defined as the proportion of Type I errors among all rejections,
FDP = V/(R∨ 1). Lehmann and Romano (2005) introduced the measure γ −FDP
which is, Pr(FDP > γ), the probability that the FDP is greater than a given value
γ. Efron et al. (2001) used an empirical Bayesian approach to FDR and introduced
the local false discovery rate.
1.2.2 Strong and Weak Control
A multiple testing method is said to strongly control an error rate if the error rate of
the method is less than or equal to a pre-specified level, say α, for any configuration
of true and false null hypotheses. A method is said to weakly control an error rate
if the error rate of the method is controlled when all null hypotheses are true. In
applications, strong control is desired as the true configuration of true and false null
hypotheses is generally unknown.
1.2.3 Definition of Power
In single hypothesis testing, power of a test is defined as the probability of rejecting
a false null hypothesis, which is 1−Pr(Type II error). Evaluation of this probability
involves the false null distribution of test statistics. In multiple testing, where several
hypotheses are tested simultaneously, various definitions of power are available to
measure and compare the performance of MTPs. It is important to choose an
appropriate definition of power in addition to a Type I error measure to evaluate
the performance of the MTP. A few commonly used concepts of power are described
below:
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The minimal power is defined as the probability of rejecting at least one false
null hypothesis,
minimal Power = Pr(S > 0).
The complete power is defined as the probability of rejecting all false null hypotheses,
complete Power = Pr(S = m1).
The average power is defined as expected proportion of rejected false null hypotheses
among all false null hypotheses,
average Power = E
(
S
m1
)
.
Another concept of power is from the false non-discovery rate given by,
1− FNR = 1− E
(
m1 − S
max{m−R, 1}
)
. (1.3)
1.3 Assumptions of MTPs
Several MTPs have been developed in the literature for various scenarios that have
different properties. The procedures can be broadly classified according to their
distributional assumptions as follows:
• p-value based Procedures: These procedures do not make any assumption about
the joint distribution of the test statistics and only rely on the univariate p-
values.
• Parametric Procedures: These procedures make specific assumptions about the
distribution of the test statistics, say the joint distribution is a multivariate
normal or a multivariate t-distribution.
• Resampling based Procedures: These procedures use resampling techniques
like bootstrap, permutation, etc., that make fewer assumptions about the
data-generating process while still exploiting the dependence structure of the
underlying test statistics in multiple testing procedures (for more details see
Dmitrienko, Tamhane and Bretz (2009)).
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1.3.1 Assumptions on p-values
The basic assumption made about the distribution of the true null p-values is that
they are bounded above by the U(0,1) distribution, that is,
Pr(Pi ≤ u) ≤ u, for any u ∈ (0, 1) for each i ∈ I0. (1.4)
Another assumption made concerns the dependence structure of the p-values. A
few common dependence structures of the p-values studied in this thesis while
developing MTPs are: independence, positive regression dependence on subset or
PRDS (Benjamini and Yekutieli (2001)) and arbitrary dependence. A set of test
statistics T = {T1, ..., Tm} is said to be positive regression dependent on subset, if for
any increasing set U , and for each i ∈ I0, Pr (T ∈ U |Ti = x) is nondecreasing in x.
Arbitrary dependence means that the test statistics may have any kind of dependence.
1.4 Procedures based on Ordered p-values
Most common MTPs are based on ordered p-values where the order of testing
hypotheses is determined by the order of magnitude of p-values. The procedures
are called stepwise methods like single-step, step-up and step-down methods. These
stepwise MTPs are described by using a sequence of non-decreasing critical constants
α1 ≤ α2 ≤ ... ≤ αm. Let, P(1) ≤ P(2) ≤ ... ≤ P(m) be the ordered p-values and
H(1), H(2), ..., H(m) be the corresponding null hypotheses.
• A step-down procedure starts with the most significant hypothesis H(1) and
goes on rejecting hypotheses until an acceptance is observed, that is, it rejects
H(1), ..., H(r) and does not reject H(r+1), ..., H(m) where r is the largest index
satisfying
P(1) ≤ α1, ..., P(r) ≤ αr.
If no such r exists then the method does not reject any hypothesis.
• A step-up procedure starts with the least significant hypothesisH(m) and goes on
accepting hypotheses until a rejection is observed, that is, it rejects H(1), ..., H(r)
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and does not reject H(r+1), ..., H(m) where r is the largest index satisfying
P(r) ≤ αr.
• A single-step procedure is a stepwise procedure with same critical constants,
α1 = α2 = ... = αm = c, that is, reject Hi if Pi ≤ c for i = 1, 2, ...,m.
1.4.1 FWER Controlling Procedures
A few popular FWER controlling procedures are discussed here. See Dmitrienko,
Tamhane and Bretz (2009) for a review of FWER controlling procedures. The
Bonferroni procedure is a widely used single-step procedure with critical constants
αi =
α
m
, i = 1, ...,m. (1.5)
The Holm procedure (Holm, 1979) is a step-down procedure that strongly controls
FWER under arbitrary dependence with the following critical constants,
αi =
α
(m− i+ 1) , i = 1, ...,m. (1.6)
The Hochberg procedure (Hochberg, 1988) is a step-up procedure with the same
critical constants as the Holm procedure and strongly controls FWER under
independence and positive dependence (Sarkar, 1998; Sarkar and Chang, 1997).
An important parametric procedure in the FWER framework is the Dunnett
procedure [Dunnett (1955); Dunnett and Tamhane (1991, 1992)]. This procedure is
developed as a powerful procedure for comparing several treatment groups with a
common control group. The test assumes that the underlying distribution of the
data from the different groups is Normal with equal variance. If θi, i = 1, ...,m and
θ0 denote the means of m treatment groups and control group, respectively, then the
hypotheses tested are: H0i : θi = θ0 against H1i : θi 6= θ0. The test assumes that the
test statistics vector (T1, ..., Tm) has a multivariate t-distribution with appropriate
degrees of freedom. The details of this procedure are discussed in Chapter 3.
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1.4.2 FDR Controlling Procedures
The Benjamini-Hochberg procedure or BH procedure (Benjamini and Hochberg, 1995)
is a step-up procedure with the following critical constants,
αi =
iα
m
, i = 1, 2, ...,m. (1.7)
Benjamini and Hochberg (1995) proved that the BH procedure strongly controls
FDR at level m0α/m under independence of the p-values. Benjamini and Yekutieli
(2001) and Sarkar (2002) proved that the BH procedure strongly controls FDR at
the same level also under positive regression dependence of the p-values. Benjamini
and Yekutieli (2001) also showed that with an appropriate modification in the critical
constants the corresponding step-up procedure can strongly control the FDR under
arbitrary dependence at level α. This procedure is called the Benjamini-Yekutieli
(BY) procedure and the critical constants are,
αi =
iα
m
∑m
j=1 1/j
, i = 1, 2, ...,m. (1.8)
Storey (2002) introduced an estimation approach to FDR that is opposite to the
approach of stepwise methods. In the stepwise methods, the rejection region (critical
constants) is determined based on the fixed FDR level, but Storey’s approach is to
fix the rejection region and estimate the FDR of the rejection region. For some other
methods, see Sarkar (2008) and Benjamini (2010).
1.4.3 Directional Errors Controlling Procedures
A few researchers have done some works on the control of directional errors
in the multiple testing. Shaffer (1980) proved that Holm’s procedure (Holm,
1979) augmented with directional decisions based on sign of test statistics controls
mdFWER under independence of test statistics and several conditions on the
distribution of the test statistics. Later, Finner (1994) and Liu (1997) independently
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proved the same result for Hochberg procedure (Hochberg, 1988) under the same
conditions for the distribution of the independent test statistics. Finner (1999)
generalized the result by Shaffer (1980) to a large class of stepwise or closed multiple
test procedures. Sarkar et al. (2004) gave a simple alternative proof to the method of
Shaffer (1980). For a good review and further discussions on the mdFWER control
of closed testing methods, refer to Shaffer (2002) and Westfall et al. (2013).
Benjamini and Yekutieli (2005) discussed control of directional errors in an
FDR set-up and proved that the BH procedure augmented with directional decisions
controls the mdFDR under independence. Guo et al. (2010) developed a two-stage
procedure for controlling mdFDR that extends the work of Benjamini and Yekutieli
(2005) to multidimensional directional decisions. In addition, some recent results
have been obtained in Guo and Romano (2015).
1.5 Procedures based on Structure of Hypotheses
In many applications, hypotheses tested have some inherent structure. For example
in clinical trials, the hypotheses pertaining to primary endpoints are more important
than those pertaining to secondary endpoints, hence the order of testing hypotheses
should be based on this knowledge instead of ordering by observed p-values.
Incorporating such prior information into the construction of multiple testing methods
leads to more powerful procedures and interpretation becomes more relevant to the
problem at hand. Another kind of structure arises in the hypotheses in applications
such as stream data analysis or Statistical Process Control where real time decisions
are made to regularly monitor the underlying process. In such situations, the
hypotheses are naturally ordered by time and require real-time decision making based
on partial information. Incorporating the partial information into the construction
of multiple testing methods leads to more appropriate procedures to make relevant
interpretation.
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Several authors developed such procedures that control FWER or FDR while
testing such structured hypotheses. To our knowledge, no procedures are developed
so far that take the underlying structure of hypotheses into account while making
directional decisions and controlling directional errors in addition to Type I errors.
The following sections briefly review the FWER and FDR controlling procedures in
this context.
1.5.1 FWER Controlling Procedures
The Fixed-sequence testing procedure (Maurer et al., 1995; Westfall and Krishen,
2001; Wiens, 2003; Wiens and Dmitrienko, 2005) is proposed for testing hypotheses
that have a pre-defined fixed order. This order reflects the relative importance or
relevance of the hypotheses, with more important hypotheses tested before the less
important ones. The testing starts with the first hypothesis, H1 and a hypothesis Hi
is rejected at the i-th step if,
Pj ≤ α, j = 1, ..., i. (1.9)
It is proved that the Fixed-sequence procedure strongly controls FWER at level α
under arbitrary dependence of p-values. A drawback of this procedure is that once a
hypothesis is accepted there is no chance of testing the rest of the hypotheses at all.
The Fallback procedure (Wiens, 2003; Wiens and Dmitrienko, 2005, 2010) is
introduced for overcoming the drawback of early stopping in fixed-sequence procedure
by allowing each hypothesis to be tested. It allocates the overall error rate α among
the hypotheses according to their weights ω1, ..., ωm where,
∑m
i=1 ωi = 1 and rejects
Hi if Pi ≤ αi where,
αi =
 ωiα + αi−1 if Hi−1 is rejectedωiα otherwise. (1.10)
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Westfall and Krishen (2001) and Dmitrienko et al. (2003) developed procedures for
testing a fixed order of families of hypotheses known as gatekeeping procedures where
hypotheses or families of hypotheses in a sequence act as gatekeeper for all the
hypotheses occurring later in the sequence. Bretz et al. (2009) proposed a graphical
approach to construct and compare weighted Bonferroni based closed test procedures
such as gatekeeping procedures, Fixed-sequence tests, and Fallback procedures.
Qiu et al. Generalized Fixed Sequence Procedure: More recently, Qiu et al.
(2014) introduced Generalized Fixed Sequence procedures whose critical values are
defined by using a function of the numbers of rejections and acceptances, and which
allows follow-up hypotheses to be tested even if some earlier hypotheses are not
rejected. In particular, their Procedure A1 is as follows:
Procedure 1.1 (Qiu et al. (2014) Procedure A1). For i = 1, . . . ,m, reject Hi if,
Pi ≤ α
m− si−1 , (1.11)
where, si−1 denotes the number of hypotheses rejected when testing H1, . . . , Hi−1.
1.5.2 FDR Controlling Procedures
Very few FDR controlling procedures have been developed in the literature that take
the underlying structure of hypotheses into account. By far the procedure by Yekutieli
(2008) is the most general procedure developed in this context. Yekutieli (2008)
discussed methodology for controlling FDR in large-scale studies that involve testing
multiple families of hypotheses arranged in a tree of disjoint subfamilies. Benjamini
and Heller (2007), Heller et al. (2009) and Guo et al. (2010) developed procedures to
control FDR in special hierarchical structures of hypotheses. Recently, Farcomeni and
Finos (2013) developed an FDR controlling fixed sequence procedure that tests each
hypothesis in sequence at level α until a stopping condition is reached. Lynch et al.
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(2014) developed an FDR controlling fixed sequence procedure that can incorporate
more than one acceptance without losing control of FDR. A few important procedures
are discussed below.
Lynch et al. Fixed Sequence Procedures: Lynch et al. (2014) proposed
multiple testing procedures for controlling FDR while testing a fixed sequence of
hypotheses. They introduce the following procedures that allow a fixed number of
acceptances. Procedure 1.2 is proved to control FDR under arbitrary dependence of
the p-values. Procedure 1.3 is a more powerful procedure that is proved to control
FDR under independence of p-values.
Procedure 1.2 (Lynch et al. (2014) Fixed Sequence method stopping on
the kth acceptance). Define,
αi =

α
k
if i = 1, . . . , k
(m−k+1)α
(m−i+1)k if i = k + 1, . . . ,m
(1.12)
Step 1: If P1 ≤ α1 then reject H1; otherwise accept H1. If k > 1 or H1 is rejected,
then continue to test H2; otherwise, stop.
Step 2: If Pi ≤ αi then reject Hi; otherwise accept Hi. If the number of hypotheses
accepted so far is less than k then continue to test Hi+1; otherwise, stop.
Procedure 1.3 (Lynch et al. (2014) Fixed Sequence method stopping on
the kth acceptance under independence). Define,
αi =
(ri−1 + 1)α
k + (i− k)α i = 1, . . . ,m (1.13)
Step 1: If P1 ≤ α1 then reject H1; otherwise accept H1. If k > 1 or H1 is rejected,
then continue to test H2; otherwise, stop.
Step 2: If Pi ≤ αi then reject Hi; otherwise accept Hi. If the number of hypotheses
accepted so far is less than k then continue to test Hi+1; otherwise, stop.
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It is clear from these procedures that though they allows testing of hypotheses
in the sequence, they do not allow testing of all the hypotheses and stop when kth
acceptance is observed. Choosing a large value for k makes these procedures very
conservative. As a result these procedures are not suitable for the application related
to real time decision making such as stream data analysis problem.
Farcomeni and Finos Sequential Procedure: The Farcomeni and Finos sequential
procedure (Farcomeni and Finos, 2013) based on a possibly data driven ordering of
the hypotheses is defined below. This procedure is proved to strongly control FDR
under independence and positive regression dependence of p-values
Procedure 1.4 (Farcomeni and Finos (2013) Algorithm). Define, J(i, α) =
i(1− α)/(2− α), where, i = 1, . . . ,m.
• Let i = 1, B(1) = I(P1 < α)
• while (B(i) > i− J(i, α) and i ≤ m) do i = i+ 1, B(i) = ∑ij=1 I(Pj < α).
• Let, u = i− 1.
• If u > 0, reject all hypotheses for i = 1, . . . , u corresponding to Pi < α. Do not
reject hypotheses for i > u even if Pi < α
Farcomeni and Finos (2013) also give a slightly more conservative procedure
under arbitrary dependence of the p-values. They show that if α is replaced with,
αD = α/
m∑
j=1
2− α
j + 1
,
in Procedure 1.4, the same procedure controls FDR at level α under arbitrary
dependence of p-values.
Though Procedure 1.4 tests the hypotheses as they occur in a sequence, the main
drawback is that if P1 > α then the whole testing stops. Also the correction factor
of the critical constant α is pretty big which makes Procedure 1.4 under arbitrary
dependence very conservative.
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G’Sell et al. (2014): G’Sell et al. (2014) proposed a procedure for a multiple
testing setting where the hypotheses are pre-ordered and one is only permitted to
reject an initial contiguous block H1, . . . , Hk, of hypotheses.
Procedure 1.5 (G’Sell et al. (2014) Forward Stop).
• Calculate,
kˆ = max
{
k ∈ {1, . . . ,m} : −1
k
k∑
i=1
log(1− Pi) ≤ α
}
. (1.14)
• Reject hypotheses H1, . . . , Hkˆ.
This procedure is proved to control FDR when the true null p-values are
independently drawn from U [0, 1] distribution. The main drawback of this procedure
is that we need to have all the data at hand to calculate kˆ. This drawback makes it
unsuitable for some applications related to real time decision making.
1.6 Motivation and Thesis Outline
In this dissertation, we focus on developing newer multiple testing procedures, for
several applications, that account for inherent structure of the tested hypotheses and
control directional errors in addition to Type I errors in some cases as required by
the problem of interest. In the following section, we discuss the motivation behind
the research.
In fields like drug development, genomics, fMRI studies etc., where a large
number of experiments are conducted daily with a varied nature of scientific
questions in the background, hypotheses with a stage-wise hierarchical structure
arise very commonly. In more complex cases, the hypotheses are grouped into several
hierarchical families, and the families are tested in a sequential order. The theoretical
and methodological issues related to multiple testing problems in this kind of special
structured hypotheses, with appropriate error rate control, require a lot of attention
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for investigation and development. A very relevant application arises in the analysis
of Uterine Fibroid Gene expression data (Davis et al., 2013) where gene expressions
of uterine fibroids and normal uterine tissues are reported. The fibroid samples are
from various size categories that correspond to different stages of tumor formation
and progression. The question of interest is to discover gene expression patterns
in the tumor tissues compared to the normal tissue. We answer this question by
formulating multiple testing of hypotheses that identify differentially expressed genes
in the fibroids compared to normal tissue, genes specific to different tumor sizes and
finally give the gene expression direction in tumor tissues compared to normal tissue.
The hypotheses formulated form a family of hypotheses for each gene consisting of one
global hypothesis for testing differential expression of the gene and several pairwise
hypotheses for testing differential expression in each tumor size compared to the
normal tissue. Directional decisions are made once a gene is found to be differentially
expressed in a tumor size. This application motivates us to develop newer mdFDR
controlling multiple testing procedure that identify genes and expression patterns
while controlling overall Type I and Directional errors.
In applications related to clinical trials, dose response study, etc., the sequence
of the tested hypotheses is often decided based on their relative importance or by some
prior knowledge. For example, in dose-response studies, the hypotheses pertaining
to a higher dose are tested before those corresponding to a lower dose; in clinical
trials, the hypotheses corresponding to a primary endpoint are tested before those
corresponding to secondary endpoint and so on. When the hypotheses are both sided
hypotheses in such applications, it is often of interest to decide on direction once
the null hypothesis of no difference is rejected. Such decisions may lead to Type
III or Directional errors. So while developing a multiple testing procedure for such
applications, it is desired to control both Type I and Type III errors. The control
of mdFWER in multiple testing is a very challenging problem and the discussion
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under dependence of the p-values is the notoriously challenging problem. This also
motivates us to consider the simple fixed sequence multiple testing problem and
develop mdFWER controlling procedures under independence and different kinds
of dependence of the p-values.
In the field of stream data analysis, statistical process control etc., the
hypotheses have a natural hierarchy due to time of occurrence of data. While testing
the hypotheses one has information only up to that time, which is only partial
information. Also as the testing sequence has a large number of hypotheses, it is
desired to control FDR. In this dissertation, we develop multiple testing procedures
that exploit the intrinsic hierarchy and structure of the hypotheses while allowing
all hypotheses to be tested irrespective of acceptances and controlling FDR. These
procedures are capable of making real time decisions based on the partial information
and conclude whether a process is going out of control or not.
The rest of the dissertation is outlined as follows. In Chapter 2, we present
a general mixed directional false discovery rate (mdFDR) controlling procedure
for testing of multiple families of hierarchically ordered hypotheses, where later
hypotheses can be tested only if their earlier counterparts are rejected with directional
decisions made in the final stage. In Chapter 3, we develop a specific methodology
based on the general procedure for application to uterine fibroid data discussed in
Davis et al. (2013) and present related simulation studies. In Chapter 4, we present
new mdFWER controlling procedures for fixed sequence multiple testing. In Chapter
5, we present FDR controlling procedures in the context of real time testing of
hypotheses while data is continuously collected as in stream data or statistical process
control. In Chapter 6, we summarize the discussions and present several possible
future works.
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CHAPTER 2
CONTROL OF MDFDR IN TESTING HIERARCHICALLY
STRUCTURED FAMILIES OF HYPOTHESES AND DIRECTIONAL
DECISIONS
2.1 Introduction
Increasingly it is a commonplace for researchers to conduct large scale genomic studies
involving multiple experimental groups along with a control group, also called the
normal or the reference group. The goal is to determine features that are differentially
expressed in a given experimental group (relative to the reference group) and to
determine if a differentially expressed feature is up or down regulated. For example, a
toxicologist may be interested in identifying differences in the gene expression profile
of spontaneous tumors and chemically induced tumors, relative to normal tissues
(Hoenerhoff et al., 2011, 2012; Pandiri et al., 2011, 2012). There is considerable
interest among cancer researchers to understand the gene expression profile of tumors
according to tumor size (Diaz et al., 2005; Gieseg et al., 2004; Hu et al., 2013; Minn
et al., 2007; Riis et al., 2013). For tumor onset and progression, it may be necessary
for some genes to express at all stages of tumor growth and development (i.e. express
in tumors of all sizes). However, some genes may express only at some specific
stages/sizes depending upon their function. For example, some may only be involved
during the early stages of tumor formation and others may be necessary for tumor
progression. Identification of genes according to tumor stages (or size) may therefore
have clinical implications. Accordingly, this has been an active area of research for
various cancers over the past decade (Ciarmela et al., 2011; Diaz et al., 2005; Gieseg
et al., 2004; Riis et al., 2013). Thus, it is clear there is considerable interest among
clinicians and biologists to investigate the expression of genes according to the tumor
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size or category. In all such investigations, one is typically interested in performing
several pairwise comparisons, of thousands of features, relative to a reference group
(e.g. normal tissue). Often researchers are not only interested in determining if a
feature is differentially expressed but are also interested in determining whether it
is up or down-regulated in the experimental group (relative to the reference group).
For simplicity of exposition, throughout this dissertation we shall replace the term
“feature” by “gene”.
Multiple testing problems involving multiple pairwise comparisons of high
dimensional data along with directional decisions has not received much attention
in the literature, yet such testing problems are commonly encountered in practice.
When the number of genes is very small (perhaps in tens) several methods have
been proposed that control the directional errors as well as the family wise error
rate (Finner, 1994, 1999; Liu, 1997; Sarkar et al., 2004; Shaffer, 1980). However,
such methods are very conservative when the number of genes is very large as in a
microarray data or CpG methylation data. Several ad-hoc methods and strategies
are used in the literature when the number of genes is large. For example, some
researchers apply multiple testing procedures (e.g. the Benjamini-Hochberg (BH) or
Bonferroni procedure) within each pairwise comparison and ignore the fact that they
are conducting several pairwise comparisons. Once a differentially expressed gene
(DEG) for a pairwise comparison is identified then they are declared to be up or
down-regulated by looking at the direction of the fold change (or the test statistic)
without accounting for the statistical error associated with such a directional decision.
Such strategies result in an inflated overall FDR due to multiple pairwise comparisons
and directional decisions. Another important approach for pattern identification in
time-course microarray data is given by Sun and Wei (2011), where they formulate
a compound decision-theoretic framework for set-wise multiple testing and propose a
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data-driven procedure to identify genes that exhibit a specific pattern of differential
expression over time.
The only formal methodology available in the literature that controls the
mdFDR for the above directional multiple testing problems is the method by Guo
et al. (2010), which is designed to make decisions on thousands of features when
making multiple pairwise comparisons and deciding on the direction of comparison.
Thus, the method controls the false discovery rate when making multiple pairwise
comparisons on thousands of genes while also controlling the directional errors
committed when falsely declaring a DEG to be up-regulated (or down-regulated)
when it is not. Guo et al. (2010) procedure generalizes the procedure of Benjamini
and Yekutieli (2005) which was designed for the case when there were only two groups
to compare.
While Guo et al. (2010) methodology is useful for making several multiple
pairwise comparisons; it is relatively conservative since it relies on the Bonferroni
procedure to deal with multiple pairwise comparisons within each significant gene.
In this chapter, we develop a general mdFDR controlling testing procedure that
allows us to use any mixed directional familywise error rate (mdFWER) controlling
procedure in place of the Bonferroni procedure, for conducting pairwise comparisons
in high dimensional data that is broadly applicable to a wide range of genomic data
including gene expression microarray data, CpG methylation data, RNA-seq data
and others. We prove that the procedure controls mdFDR when the underlying
test statistics are independent across the genes. Based on this general procedure,
we develop a specific methodology in Chapter 3 using the Dunnett’s test (Dunnett,
1955; Dunnett and Tamhane, 1991, 1992) which is designed for making comparisons
of several experimental groups with the control or the reference group.
The rest of the chapter is organized as follows. Section 2.2 gives a summary
of notation and concepts used in this chapter and describes the formulation of the
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problem. Section 2.3 introduces a general three-step procedure. Section 2.4 gives
some insight on developing specific methodology based on the general procedure. In
Section 2.5 we discuss some future work related to this project.
2.2 Background, Notations and Problem Formulation
Figure 2.1 shows a typical microarray gene expression data with genes arranged
vertically and tumor samples (categorized by, for example, size of tumor) arranged
horizontally. In the uterine fibroid gene expression data explained in Davis et al.
Figure 2.1 A typical microarray gene expression data arranged in rows and columns.
Rows represent genes and columns represent tissue samples.
(2013), the tumor samples are categorized according to tumor size, tumor location,
race and age of women the samples are taken from, etc. The interest here is to identify
genes that are differentially expressed across these categories and find the pattern
of gene expression across these categories. For example, an important question of
interest is identifying genes and pathways that are specific to early stages of tumor
formation (i.e. small/tiny tumors), genes that are specific to tumor growth (i.e.
medium size tumors) and those genes that are specific to very large tumors which
may be necrotic. By identifying such genes, the researcher may potentially discover
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co-regulated genes belonging to similar pathways and gain insights into biological
functions and processes of groups of genes with similar patterns of expressions. This
kind of analysis requires several steps of analysis that requires multiple testing of
families of hypotheses and making multidimensional directional decisions.
Motivated by this we formulate the problem as a three-step multiple testing
problem where we first test for significance of each gene for differential expression
across categories, then test families of hypotheses corresponding to significant genes
and finally conclude on the pattern of gene expression by making directional decisions.
The procedure gives rise to the possibility of committing two kinds of errors: Type
I and Directional errors or Type III errors. So the overall error measure we want to
control is mixed directional FDR (mdFDR). For identifying gene expression patterns
for different sizes of tumors, the three steps are described as follows.
• Step 1: Identify genes that are differentially expressed in tumor tissues
compared to normal tissues. We test a global hypothesis corresponding to each
family (gene), testing for difference in expression in tumor samples compared
to normal samples while controlling FDR.
• Step 2: Identify in which category (e.g., size of tumor) these genes are
differentially expressed compared to normal tissues. For each significant family,
we test individually the difference in expression of tumor samples of each size
compared to normal tissue.
• Step 3: Identify the direction of expression compared to normal tissue. For the
hypotheses that are rejected in Step 2, we decide on direction of expressions of
tumor samples (pertaining to different categories) versus normal samples, while
controlling mdFWER combining Steps 2 and 3. Overall we aim at controlling
mdFDR.
We now introduce some notations and definitions related to the problem. Let
m denote the number of genes in the data that has gene expressions for each gene
on p categories. Let µij denote the mean response corresponding to the i-th category
in j-th gene, i = 1, ..., p, j = 1, ...,m. Let q denote the number of hypotheses to be
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tested based on a set of pairwise differences of mean responses of p categories. The set
of q hypotheses in each gene depend on the problem of interest and a few examples
are as follows. A problem of biological interest in the context of uterine fibroid data is
to group genes that are differentially expressed in a size category of tumor compared
to normal sample, if category “p” correspond to normal sample, then we need to test
the differences θij = µij − µpj, i = 1, 2, ..., q and j = 1, 2, ...,m, here, q = p− 1.
Based on the three steps, we introduce the hypotheses to be tested in each step
as follows. For each gene j, we have a vector of parameters θj = (θ1j, θ2j, ..., θqj). We
define the null and alternative “screening hypotheses” to test the significance of each
gene as,
Hj0screen : θj = 0 against H
j
1screen : θj 6= 0, j = 1, . . . ,m. (2.1)
For each gene j, the component null and alternative hypotheses are,
Hj0i : θij = 0 against H
j
1i : θij 6= 0, i = 1, . . . , q. (2.2)
Figure 2.2 shows a simple graphical representation of the structure of hypotheses in
our formulation. Let Tij and Pij, i = 1, 2, . . . , q, j = 1, 2, . . . ,m, denote the test
Figure 2.2 A graphical display of the hypotheses in uterine fibroid gene expression
data problem.
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statistics and the p-values respectively for testing the hypotheses in equation (2.2).
The screening hypotheses form a global test which test whether all parameters
θij, i = 1, ..., q are simultaneously 0 or not or equivalently, whether all µij, i =
1, ..., p are equal or not. We denote the p-values for testing screening hypotheses
in equation (2.1) as P jscreen. For each family j we denote a vector of p-values,
Pj = (P1j, P2j, ..., Pqj) based on the test statistics Tj = (T1j, T2j, ..., Tqj), for testing
the component hypotheses in equation (2.2). If Hj0i is rejected we conclude on
direction, i.e., declare θij > 0 if Tij > 0 or declare θij < 0 if Tij < 0.
Given the screening p-values P jscreen, for every j = 1, 2, ...,m, to carry
out the simultaneous testing of the screening hypotheses in equation 2.1, we use
the BH-procedure (Benjamini and Hochberg, 1995), as suggested by Guo et al.
(2010), that controls the FDR at a given level α. This is a step-up procedure
as follows: given ordered p-values Pscreen(1) ≤ Pscreen(2) ≤ · · · ≤ Pscreen(m) and
the corresponding null hypotheses H0screen(1), H0screen(2), ..., H0screen(m), find R =
max {1 ≤ j ≤ m : Pscreen(j) ≤ jα/m} and reject H0screen(1), ..., H0screen(R) provided
the maximum exists, otherwise, accept all the screening hypotheses.
When an Hj0screen : θj = 0 is rejected using the BH procedure, further decisions
are made on the component hypotheses in equation (2.2) and on rejection, directional
decisions are made on the signs of the component θij. A Type I error might occur
due to wrongly rejecting Hj0i : θij = 0 and a directional error might occur due to
correctly rejecting Hj0i : θij = 0 but wrong assignment of the sign of θij. So we need
to control Type I as well as Type III (directional) errors. A practical way of doing
that would be to use an error rate combining both Type I and Type III errors in the
FDR framework and make sure that it is controlled.
An error rate that combines Type I errors and Type III errors in FWER
setup is mdFWER (Finner, 1999; Shaffer, 1980), see also equation (1.1). Benjamini
and Heller (2008) introduced the error rate Overall False Discovery Rate (OFDR)
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in the context of testing of partial conjunction hypotheses. Heller et al. (2009)
used this error rate, as an appropriate error measure to control, in their two-stage
procedure for identifying differentially expressed gene sets. Inspired by Heller et al.
(2009) and Shaffer (1980) we augment directional decisions to the two-stage OFDR
controlling procedure and develop a three-stage procedure that controls mdFDR as
appropriate overall error measure while identifying significant families, consequently
finding significant hypotheses and finally concluding on direction of parameters for
those significant hypotheses. The definition of overall mdFDR is given below.
Let V (j) denote the indicator function of at least one Type I error or Directional
Error committed while testing family j and the component hypotheses in it, i.e., V (j)
is 1 if either Hj0screen is falsely rejected or H
j
0screen is correctly rejected but at least
one Type I error or Directional error occurs while testing component hypotheses
corresponding to gene j; V (j) is 0 otherwise. Let R denote the number of families
discovered. Then mdFDR is formally defined as follows.
Definition 2.1 (mdFDR - mixed directional False Discovery Rate). The
expected proportion of Type I and Directional errors among all discovered families.
mdFDR = E
[∑m
j=1 V (j)
R ∨ 1
]
. (2.3)
2.3 A General Mixed Directional FDR Controlling Procedure
In this section we present a general procedure for testing hierarchically structured
families of hypotheses, given in Section 2.2, with multidimensional directional
decisions made in the final step, while controlling the mdFDR as the overall error
measure. The general procedure is summarized as follows:
Procedure 2.1 (General Hierarchical Procedure Controlling mdFDR).
1. Use BH procedure to find significant genes. Let Pscreen(j), j = 1, ...,m, be
the ordered screening p-values ordered from smallest to largest, and Hscreen(j)
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be the corresponding screening hypotheses. Conclude gene j as significant if
Pscreen(j) ≤ jαm . Let R denote the number of significant genes.
2. For each significant gene, use any mdFWER controlling procedure such as Holm,
Hochberg etc., at level Rα
m
.
3. For the component hypotheses rejected for each significant gene, conclude on
direction based on the sign of the test statistic to identify directional pattern.
Remark 2.1. This procedure is general in the sense that any global testing method
can be used to obtain the screening p-values in Step 1 of the procedure, any pairwise
comparison testing method can be used to obtain the pairwise p-values in Step 2 and
any mdFWER controlling procedure can be used in Steps 2-3 of the procedure.
Remark 2.2. Note here that the method of Guo et al. (2010) is a special case of
the proposed general procedure in which Bonferroni global test is used for testing
the screening hypotheses and Bonferroni method along with additional directional
decision works as the mdFWER controlling procedure.
It is important to point out that the goal of this chapter is to identify expression
patterns of m genes over p categories which give rise qm hypotheses in total. We treat
this as a problem of performing m tests each involving q-dimensional hypotheses. The
procedure controls FDR in Step 1 while testing the m screening hypotheses using BH
procedure. Each significant family of hypotheses is then tested in Step 2 using an
mdFWER controlling procedure. So the control of overall error rate is achieved by
controlling the mdFWER for each individual family.
2.3.1 mdFDR Control under Independence
Assumption 2.1 (Independence). The test statistics vectors Tj = (T1j, T2j, ..., Tqj),
j = 1, ...,m are independent and consequently, the P -value vectors {Pj, j = 1, 2, ...,m}
are independent.
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Theorem 2.1. Under Assumption 2.1, the mdFDR of Procedure 2.1 is strongly
controlled at level α for any procedure controlling mdFWER at level Rα
m
at Step 2
of Procedure 2.1.
Proof Let, I0 denote the set of true null screening hypotheses H
j
0screen and I1 denote
set of false Hj0screen with |I0| = m0 and |I1| = m1, m0 +m1 = m. From definition 2.1,
mdFDR = E(Q) = E
[∑m
j=1 V (j)
R ∨ 1
]
.
In the event that R = r, Pscreen(k) ≤ rα/m for k = 1, 2, ..., r and Pscreen(k) >
(r+ 1)α/m for k = r+ 1, ...,m. Consequently, we have r number of P jscreen’s that are
≤ rα/m. Then mdFDR will be equal to,
E(Q)
=
m∑
r=1
1
r
[
m∑
j=1
Pr(V (j) = 1, R = r)
]
=
m∑
r=1
∑
j∈I0
1
r
Pr
(
P jscreen ≤
rα
m
, R(−j) = r − 1
)
+
m∑
r=1
∑
j∈I1
1
r
Pr
(
P jscreen ≤
rα
m
,Type I or Type III error at j, R(−j) = r − 1
)
.
(2.4)
where, R(−j) denotes the number of screening hypotheses rejected form the set
{H1, H2, ..., Hj−1, Hj+1, ..., Hm}, the set of screening hypotheses excluding the j-th
one.
Consider the second term in equation (2.4):
m∑
r=1
∑
j∈I1
1
r
Pr
(
P jscreen ≤
rα
m
, type I or type III error at j, R(−j) = r − 1
)
=
m∑
r=1
∑
j∈I1
1
r
Pr
(
P jscreen ≤
rα
m
, type I or type III error at j
)
Pr
(
R(−j) = r − 1)
(2.5)
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≤
m∑
r=1
∑
j∈I1
1
r
rα
m
Pr
(
R(−j) = r − 1) (2.6)
=
m1α
m
. (2.7)
The equality in (2.5) follows due to Assumption 2.1. The inequality in (2.6) follows
due to the procedure we use which controls the mdFWER at level rα
m
and as j ∈ I1,
the probability of making at least one Type I error or directional error in family j
is ≤ rα
m
. Summing over all values of r, the equality in (2.7) follows by noting that∑m
r=1 Pr
(
R(−j) = r − 1
)
= 1.
Next consider the first term in eq (2.4):
m∑
r=1
∑
j∈I0
1
r
Pr
(
P jscreen ≤
rα
m
, R(−j) = r − 1
)
=
m∑
r=1
∑
j∈I0
1
r
Pr
(
P jscreen ≤
rα
m
)
Pr
(
R(−j) = r − 1) (2.8)
≤
m∑
r=1
∑
j∈I0
1
r
rα
m
Pr
(
R(−j) = r − 1) (2.9)
=
m0α
m
. (2.10)
The equality in (2.8) follows due to Assumption 2.1. The inequality in (2.9) follows
due to the procedure we use, it controls the mdFWER at level rα
m
. Summing over all
values of r, the equality in (2.10) follows by noting that
∑m
r=1 Pr
(
R(−j) = r − 1) = 1.
The result follows by combining equations (2.7) and (2.10). 
Remark 2.3. Note that this theorem is proved under the assumption that the m
P -value vectors are independent. This assumption is used only in Step 1 of the general
procedure. In the case that we are not sure whether this assumption is satisfied or not,
the BH procedure can be replaced by the more conservative BY procedure (Benjamini
and Yekutieli, 2001), which shows control of FDR under arbitrary dependence. We
do not yet make any assumption about the structure of p-values within a family.
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Assumption 2.1 only implies that the p-values across families are independent and
which in turn implies that the summary p-values P jscreen are independent.
2.4 Methodology
Several application specific methodology can be developed from this general procedure
by choosing appropriate methods to obtain P jscreen and Pij, i = 1, ..., q, j = 1, ...,m
and choosing an appropriate mdFWER controlling procedure for Steps 2 and 3. In
this section we discuss a few ways of obtaining these P jscreen and Pij.
2.4.1 Choices of Methods for P jscreen
For testing Hj0screen vs. H
j
1screen, we have several types of the global testing methods
available based on which the screening p-values, P jscreen, can be obtained. A few
examples are Bonferroni method, ANOVA, Dunnett method. Here, we discuss how
to obtain P jscreen’s for the first two methods, the Dunnett method will be discussed
in details in Chapter 3.
Let xjik denote the gene expressions, for, i = 1, ..., p categories, j = 1, 2, ...,m
genes, and k = 1, 2, ..., ni samples in category i. Let Tij denote the test statistic for
testing the component null hypotheses in equation (2.2). Let Tij ∼ Fij (t, θij) for some
continuous cdf F which is symmetric about 0 under Hj0i with Fij (t, θij) ≥ Fij (t, 0) if
θij < 0 and Fij (t, θij) ≤ Fij (t, 0) if θij > 0. The two-sided P -value for testing (2.2) is
defined as,
Pij = 2 min {Fij(Tij, 0), 1− Fij(Tij, 0)} . (2.11)
Bonferroni Adjusted Pscreen: If we treat H
j
0screen as an intersection of the
component null hypotheses, that is, Hj0screen = ∩qi=1Hj0i and Hj1screen = ∪qi=1Hj1i, then
we can combine the three component p-values {P1j, ..., Pqj} by using Bonferroni
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adjusted pooling method and get the Bonferroni adjusted Pscreen’s as,
P jscreen = q min {P1j, ..., Pqj} . (2.12)
The procedure to obtain Tij and the assumptions of their distribution need to be
discussed here. The data can be assumed to be approximately normal as the data
we have are normalized gene expressions. Then the test statistic for testing the
component hypotheses (2.2) is given by the two sample t-test statistic,
Tij =
x¯ij − x¯pj
spooled(ip)j
√
1
ni
+ 1
np
, (2.13)
where, for i = 1, ..., q,
s2pooled(ip)j =
(ni − 1)s2ij + (np − 1)s2pj
ni + np − 2 , (2.14)
and for i = 1, ..., p,
x¯ij =
∑ni
k=1 x
k
ij
ni
, (2.15)
s2ij =
∑ni
k=1
(
xkij − x¯ij
)2
ni − 1 . (2.16)
The test statistic Tij has a t-distribution with (ni + np − 2) degrees of freedom and
s2pooled(ip)j is the pooled variance of groups i and p. The corresponding component
p-values are given by,
Pij = 2× (1−Gt(|Tij|, ni + np − 2)) , i = 1, ..., q, (2.17)
where, Gt(·, ni + np − 2) denotes the CDF of t-distribution with ni + np − 2 degrees
of freedom. This is the procedure, adopted by Guo et al. (2010), for obtaining Pscreen.
ANOVA Pscreen: ANOVA gives us a direct method to obtain P
j
screen from the data
for testing (2.1). The ANOVA global F -test tests the hypotheses Hj0 : µ1j = · · · = µpj
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vs. Hj1 : at least one µij is not equal. Rejection of this null hypothesis is equivalent
to rejection of null hypothesis in (2.1). The test statistic for testing (2.1) is given by
the ratio of between group variance and within group variance,
TANOV Aj =
∑p
i=1 ni (x¯ij − x¯j)2 /(p− 1)∑p
i=1
∑ni
k=1
(
xkij − x¯ij
)2
/(
∑p
i=1 ni − p))
, (2.18)
where,
x¯j =
∑p
i=1
∑ni
k=1 x
k
ij∑p
i=1 ni
, (2.19)
and the other terms are as described in equations (2.14)-(2.16). The null distribution
of TANOV Aj is F (·, p− 1,
∑p
i=1 ni − p), an F -distribution with (p − 1,
∑p
i=1 ni − p)
degrees of freedom.
2.4.2 Choices of mdFWER Controlling Methods
The statistical problem in Steps 2 and 3 is to decide how to construct the test statistics
for each component hypothesis and obtain the corresponding component p-values that
will then be used in an appropriately chosen mdFWER controlling testing procedure
to identify significantly expressed categories and direction of expression. For an
identified gene, each of the component null hypothesis is tested using the two-sample
t-test statistic. The component hypotheses test statistics can be obtained using (2.13)
and the corresponding p-values are obtained using (2.11), where, Ft (·, ni + np − 2)
denotes the CDF of t-distribution with (ni + np − 2) degrees of freedom, i = 1, ..., q.
We present a few mdFWER controlling multiple testing methods for identifi-
cation of significantly differentially expressed categories and describe how the methods
are implemented. Some of the few available mdFWER controlling procedures
are Holm procedure, Hochberg procedure, Fixed Sequence procedure, Bonferroni
procedure and Dunnett procedure. The details of the Dunnett procedure are
described in Chapter 3. We discuss the rest of the procedures below. For each
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procedure, once a null hypothesis is rejected, the sign of the parameter θij is decided
based on the sign of the test statistic Tij. Holm’s procedure and Hochberg’s procedure
use ordered p-values. Let, Pj(1) < Pj(2) < · · · < Pj(q) denote the ordered Pij and the
corresponding component null hypotheses be Hj0(1), H
j
0(2), . . . , H
j
0(q).
Holm Procedure: Shaffer (1980) proved that the Holm’s procedure (Holm,
1979), when augmented with directional decisions, can control mdFWER under
independence of the p-values. We use Holm’s step-down procedure at level Rα
m
within
each significant gene. Let k be the maximum index such that Pj(k) ≤ Rαm(q−k+1) ,
k = 1, 2, . . . , q, then reject Hj0(1), ..., H
j
0(k) and accept the rest of the hypotheses.
Hochberg Procedure: Liu (1997) and Finner (1999) independently proved
that the Hochberg’s procedure (Hochberg, 1988), when augmented with directional
decisions, can control mdFWER when the p-values are independent. We use
Hochberg’s step-up procedure at level Rα
m
within each significant gene to identify
significant categories. Let k be the minimum index such that Pj(k) >
Rα
m(q−k+1) ,
k = 1, 2, . . . , q, then reject Hj(1), ..., Hj(k− 1) and accept the rest of the hypotheses.
Fixed Sequence Procedure: Fixed Sequence procedure is commonly used
in scenarios where the order of testing of hypotheses is fixed beforehand. We
prove in Chapter 4 that the Fixed Sequence procedure augmented with directional
can strongly control mdFWER when the p-values are independent or positively
dependent. We use Fixed Sequence procedure at level Rα
m
within each significant gene
to identify significant categories. Let k be the minimum index such that Pkj >
Rα
m
,
k = 1, 2, . . . , q, then reject Hj01, ..., H
j
0k−1 and accept the rest of the hypotheses.
Bonferroni Procedure: Bonferroni procedure is a single step multiple testing
procedure and it can strongly controls mdFWER when augmented with directional
decisions. We use Bonferroni procedure, as described in Guo et. al. (2010), at
level Rα
m
within each significant gene to identify significant categories. The procedure
rejects Hj0i if Pij ≤ Rαqm .
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2.5 Discussion and Conclusion
In this chapter, we developed a general mdFDR controlling procedure that allows
testing of hierarchically ordered families of hypotheses while making multidimensional
directional decisions. We have shown that Procedure 2.1 controls mdFDR as an
overall error measure under the independence of test statistic vectors across families.
We have not assumed any specific dependence structure for the test statistics within
a family, so the joint distribution of the statistics within a family may have any
dependence structure. The simulations studies that we present in Chapter 3 give
an indication that we can relax the assumption of independence of the test statistic
vectors.
The generality of this procedure makes it a flexible procedure to apply to several
practical situations where multidimensional directional decisions are required to make.
Although, in Section 2.2 we discuss comparison of gene expressions in each tumor size
to the gene expressions in the normal sample, this procedure can be applied to any
type of pairwise comparison desired to be tested for each gene. For example, if it is
of interest to group genes by the inequalities among the mean responses, we would
want to detect the pattern of mean responses in the p categories, known as directional
pattern, and see how the mean responses vary across the categories. Some common
inequalities are µ1j ≤ µ2j ≤ · · · ≤ µpj (monotone pattern), µ1j ≤ · · · ≤ µij ≥
µ(i+1)j ≥ · · ·µpj (umbrella pattern with peak µij). To test for the pattern we need to
test the differences of mean response of the categories, θij = µi+1j − µij, i = 1, 2, ..., q
and j = 1, 2, ...,m and q = p − 1. If the problem of interest is testing all pairwise
differences of the p categories, possibly unordered, then q = p(p− 1)/2. Based on the
question we want to answer from a data, appropriate methodology can be developed
from this general procedure.
Hypotheses such as the above can also be tested in the order restricted inference
framework as done in Peddada et al. (2003, 2005), a problem with order restricted
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inference based methods is that one cannot distinguish between strict inequalities and
non-strict inequalities. Although such issues also arise in the present setting because
failure to reject null does not imply that the null is true, to a larger extent the
problem is reduced by adopting the present strategy. One could consider including
a bioequivalence type testing to make sure the null hypothesis is true, but that is
beyond the scope of this research.
The general procedure proposed in this chapter provides an interesting view
towards the challenging problem of controlling both Type I and Directional errors in
multiple testing involving multidimensional parameters. We showed control of overall
mdFDR of Procedure 2.1 under assumption of independence across the families.
In microarray data, gene expressions are obtained by drawing samples from same
subjects. In such cases, there may be dependence in gene expressions from several
genes, which leads to dependence of test statistics across families. It will be interesting
to theoretically investigate the performance of the proposed procedure under such
dependence structures.
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CHAPTER 3
METHODOLOGY FOR UTERINE FIBROID DATA
3.1 Introduction
In this chapter, we develop a specific methodology based on the general procedure,
developed and discussed in Chapter 2, to analyze a gene expression data (Davis
et al., 2013) obtained from the NIEHS Fibroid Growth Study (FGS) (Peddada et al.,
2008). Uterine fibroids, also called uterine leiomyoma, are benign smooth muscle
tumors which are hormonally mediated. According to some estimates, the cumulative
incidence by age 50 of these tumors among Caucasian women exceeds 70% and it is
much higher among women of African American descent. The direct and indirect
annual cost of fibroids in the US is as high as 34 billion dollars. While several
studies investigated the molecular characteristics of these benign tumors relative to
normal myometrium (Davis et al. (2013) and references therein) not many have been
conducted to identify genes that are specific to fibroid size. However, such studies
have been conducted for other tumors (Diaz et al., 2005; Gieseg et al., 2004; Hu et al.,
2013; Minn et al., 2007; Riis et al., 2013). Using the gene expression data obtained in
the NIEHS FGS and the methodology developed in this chapter, we identify DEGs
and pathways that are specific to tumor size of uterine fibroids.
Since the idea is to compare the gene expressions in different sizes of fibroids to
the expression in normal uterine tissue, the comparison is of the type where several
treatments are compared to a common control. Dunnett procedure (Dunnett, 1955),
a single step procedure which uses a multivariate t-distribution of the test statistics
to derive the p-values, is specifically introduced for testing hypotheses in this kind
of comparison. We incorporate this procedure into the general Procedure 2.1 to
obtain a methodology appropriate for analyzing the FGS gene expression data. Not
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only that the resulting methodology is practically relevant but as demonstrated in
the numerical simulations, the resulting methodology not only controls the mdFDR
but is more powerful relative to some potential alternative methods. We report the
results of a simulation study evaluating the performance of the proposed procedure
under independence and dependence of the underlying test statistics and compare
our procedure to the method of Guo et al. (2010). The simulation studies show this
methodology to have highest power among other relevant methodologies developed
from Procedure 2.1.
Using our methodology we gain deeper insights into molecular characteristics of
uterine fibroids according to the tumor size. We have identified several differentially
expressed genes and pathways that are specifically enriched according to the tumor
size (or stage of growth). While researchers and clinicians who study fibroids are well
aware of many of the genes and pathways described in this chapter, we have provided
a characterization of these genes and pathways according to the tumor stage. Our
data can be further mined to gain deeper insights regarding fibroids.
The rest of the chapter is organized as follows. Section 3.2 describes the gene
expression data. Section 3.3 describes the methodology developed, derived from the
general procedure introduced in the Chapter 2, for the analysis of data. In Section
3.4, we present a simulation study to compare the specific procedures we consider.
In Section 3.5, we present the results of the data analysis. In Section 3.6, we give a
brief summary and discussion of the results.
3.2 Uterine Fibroid Gene Expression Data
In their study, Peddada et al. (2008) prospectively tracked growth of fibroids in 72
premenopausal women (38 black and 34 white) over 12 months period and found that
growth rates of fibroids were on average much higher in older black women than in
older white women. Davis et al. (2013) reported gene expression pattern differences in
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tumors and myometrium samples from 12 study participants who underwent surgery
during the course of the study. They analyze 52 leiomyoma (fibroid) and 8 myometrial
(normal tissue) samples using Affymetrix Gene Chip expression arrays and report
genes that were found significant in the comparison of tumor and normal myometrium
samples.
The data contains normalized gene expressions of 54675 probe sets from 52
tumor samples and 8 normal myometrium samples, so in total we have 60 tissue
samples. The tumor samples are classified by tumor size into three groups: Small
(14 samples, volume: 0.08-5.70), Medium (25 samples, volume: 9.0-132.00), Large
(13 samples, volume: 240-2016). The three sizes of fibroids and normal samples form
four ordered categories of the attribute “size of tumor”. We have data for each gene
in an unbalanced one-way format.
3.3 Methodology for FGS Gene Expression Data
Suppose we are interested in comparing “q” experimental groups with a reference
group (in total, p = q + 1 groups) on the basis of the mean expression of “m” genes.
For example, suppose we are interested in comparing “small”, “medium” and “large”
fibroids with a “normal” tissue (also called normal myometrium) from uterus on the
basis of “m” genes. Our goal is not only to identify differentially expressed genes
in any given pairwise comparison but also to determine if the mean expression is up
or down-regulated in the tumor tissue compared to the normal myometrium. Our
statistical methodology for the FGS gene expression data analysis proceeds in three
steps as follows.
1. For each gene we obtain a Dunnett (Dunnett, 1955; Dunnett and Tamhane,
1991, 1992) based screening p-value from all “q” pairwise comparisons with the
reference group. Apply the BH procedure Benjamini and Hochberg (1995) on
these screening p-values to obtain genes that are differentially expressed in at
least one pairwise comparison. Suppose we discover R genes in this step. Thus,
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there are R genes which are differentially expressed in at least one pairwise
comparison with the reference group.
2. For the jth gene discovered in Step 1, we compute Dunnett’s p-value Pij for each
pairwise comparison i, i = 1, 2, . . . , q, with the reference group. If Pij ≤ Rαm
then we declare that the ith pairwise comparison with the reference group is
significant.
3. If a gene j is found to be significant in the ith pairwise comparison with the
reference group then we declare it to be up-regulated in the ith group relative
to the reference group if Tij > 0, otherwise it is declared to be down-regulated.
Here Tij denotes the test statistic associated with the j
th gene in the ith pairwise
comparison.
Specific details of implementation of each step are described in the following sections.
3.3.1 Step 1 - Identifying Differentially Expressed Genes
For this data and analysis of tumor sizes vs. myometrium we have, m = 54675, p = 4
and q = 3. The data we have is gene expressions xjik, say, i = 1, ..., p, j = 1, 2, ...,m,
k = 1, 2, ..., ni, with, n1 = 13, n2 = 25, n3 = 14 and n4 = 8. The screening and the
component null and alternative hypotheses we want to test are as in equations (2.1)
and (2.2). All the notations used here are defined in Section 2.4.
Dunnett Pscreen: Dunnett test (Dunnett, 1955) is a powerful method that is designed
specifically for comparison of several treatment groups with a common control group.
The test assumes that the underlying distribution of the data from the different groups
have same variance and the test statistics are obtained by using a pooled estimate
of the variance. This assumption is valid for the Uterine fibroid data as the gene
expressions are normalized to have similar means and variances for comparison. The
test statistic for testing (2.2) is given by,
TDunnij =
x¯ij − x¯pj
sj
√
1
ni
+ 1
np
, (3.1)
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where,
s2j =
∑p
i=1
∑ni
k=1
(
xkij − x¯ij
)2∑p
i=1 ni − p
(3.2)
is the pooled sample variance. The null distribution of each TDunnij is univariate
t-distribution with (
∑p
i=1 ni − p) degrees of freedom. The vector of Dunnett test
statistics TDunnj =
(
TDunn1j , T
Dunn
2j , ..., T
Dunn
p−1j
)
has a (p−1)-variate t-distribution with
ν = (
∑p
i=1 ni − p) degrees of freedom and correlation matrix R = (ρik)ik, where for
i 6= k,
ρik =
√
ni
ni + np
√
nk
nk + np
, i, k = 1, 2, ..., p− 1. (3.3)
The Dunnett-adjusted critical value for the two-sided test for
{
TDunnij , i = 1, ..., p− 1
}
,
denoted by uα(p−1, ν), is the quantile of the above (p−1)-variate t-distribution such
that,
Pr
(∣∣TDunn1j ∣∣ ≤ uα, ..., ∣∣TDunnp−1j ∣∣ ≤ uα) = 1− α2 , (3.4)
or equivalently,
Pr
(
max
{i=1,...,p−1}
∣∣TDunnij ∣∣ ≤ uα) = 1− α2 . (3.5)
The observed values of TDunnij , t
Dunn
ij , say, are compared to uα(p− 1, ν) and we reject
Hj0i if
∣∣tDunnij ∣∣ > uα(p− 1, ν). For our data, ν = 56, p = 4 and u0.05(3, 56) =
2.657. For each gene j we have a vector of observed Dunnett test statistics,
tDunnij =
(
tDunn1j , t
Dunn
2j , t
Dunn
3j
)
. Let, tmaxj = maxi=1,2,3
∣∣tDunnij ∣∣. We obtain the screening
P -value for testing the screening hypotheses (2.1) as,
P jscreen = Pr
(
max
{i=1,2,3}
∣∣TDunnij ∣∣ > tmaxj )
= 1− Pr (−tmaxj ≤ TDunnij ≤ tmaxj , i = 1, 2, 3) , (3.6)
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where, the probability in equation (3.6) is obtained from the CDF of 3-variate t-
distribution with ν degrees of freedom and the correlation structure given in (3.3).
Alternately, we can also compare the maximum of absolute value of the test
statistics to u0.05(3, 56),
TDunnettj = max
{∣∣TDunnij ∣∣ , i = 1, 2, 3} . (3.7)
Reject (2.1) and declare gene j significant if TDunnettj > u0.05(3, 56).
3.3.2 Step 2 - Identifying Significant Pairwise Comparisons
Once the differentially expressed genes are identified, we move on to the next step
and answer the question in which tumor sizes, the genes are expressed differentially
compared to the normal myometrium. Let DE ⊆ {1, 2, ...,m} denote the set of
indices of the identified genes. We denote the number of genes identified by R, that
is,
R = |DE| . (3.8)
In this step, we test the component hypotheses for only identified genes and apply
the Dunnett mdFWER controlling procedure for each gene, at level Rα/m, while
identifying the tumor sizes and this procedures will be augmented with directional
decisions in Step 3 of the analysis such that the overall error measure controlled for
each gene is mdFWER at level Rα/m. The method is described as follows:
Dunnett Procedure: We use Dunnett procedure as described in Step 1 of section
3.3.1 and obtain the Dunnett-adjusted p-values and call them P˜ij
Dunnett
,
P˜ij
Dunnett
= 2 · Pr
(
max
{i=1,...,q}
∣∣TDunnij ∣∣ ≥ tDunnij ) , (3.9)
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where, TDunnij and t
Dunn
ij are defined in section 3.3.1 while discussing the Dunnett
screening procedure. We reject Hj0i if the corresponding adjusted P -value P˜ij
Dunnett ≤
Rα
m
.
3.3.3 Step 3 - Directional Decisions
Once we find out significantly expressed categories for each differentially expressed
gene, we conclude on direction based on the sign of the test statistics. That is, declare
θij > 0 if T
Dunn
ij > 0 or vice versa.
For example, let gene j be identified as significant in Step 1 of the analysis.
The corresponding component hypotheses, in equation (2.2), are tested in Step 2.
Suppose that the first two component hypotheses are rejected and the third one is
not rejected, then we have, θi1j 6= 0, θ2j 6= 0. That is, µ1j 6= µ0j and µ2j 6= µ0j. In
Step 3 of the analysis, we look at the sign of the test statistic corresponding to the
rejected component hypothesis and decide on the direction as follows: if T1j > 0 then
conclude µ1j > µ0j and vice versa.
3.4 Simulation Study
A simulation study was conducted to evaluate the performance of the specific
procedures obtained by combinations of several procedures, described for use in Steps
1 and 2, explained in Section 2.4 and Section 3.3. The procedure with Bonferroni
screening procedure and Bonferroni single step procedure in Step 2 is the procedure
given by Guo et al. (2010). We address the following questions in the simulation
study:
1. How do the procedures compare among themselves in terms of mdFDR and
power under independence as well as different types of dependence of test
statistics and p-values within a family?
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2. How do the procedures compare among themselves in terms of mdFDR and
power under independence as well as different types of dependence of hypotheses
across families?
For comparison of mdFDR we use definition 2.1 to evaluate mdFDR for a procedure.
For comparison of power we use the concept of average power defined as follows.
Definition 3.1 (Average Power). The average power is defined as the expected
proportion of false null hypotheses rejected in Steps 1 and 2 among all rejections in
Steps 1 and 2,
Average Power = E
(
Number of correct decisions in Steps 1 and 2
Number of rejections in Steps 1 and 2
)
. (3.10)
3.4.1 Study Design
In our simulation we considered p = 4 groups, the first three were taken to be
experimental groups and the last group was taken to be the reference group. Thus, all
pairwise comparisons are made with the last group. Our simulated microarray chip
consisted of m = 1000 genes per chip with n = 10 chips per group. As often done
in simulation studies for microarray data (Dudoit et al., 2003; Efron and Tibshirnai,
2002; Efron et al., 2001; Guo et al., 2010), we generated the expression of each gene
in each chip using a normal distribution.
More precisely, for the jth gene, j = 1, 2, . . . , 1000, in the sth sample, s =
1, 2, . . . , 10 in the gth group, g = 1, 2, 3, 4, we generated its expression Zsgj from a
normal distribution with mean value E(Zsgj) = µgj and variance V (Z
s
gj) = 1. For the
reference group (i.e. group 4) we set µ4j = 0 for all j. To create the null data we set
µgj = 0 for j = 1, 2, . . . ,m0, g = 1, 2, 3 and non-null data were created by generating
µgj ∼independent U(0, 2.5), for g = 1, 2, 3 and j = m0 + 1,m0 + 2, . . . ,m0 + m1, where
m1 = m − m0 and U represents the uniform distribution. It is important to note
that, for the non-null means considered here, the standard deviation used in this
simulation study is large. Consequently, all methods considered in this simulation
43
study are expected to have small power. We considered three patterns of correlation
structure as follows: (a) Independent gene expressions: the correlation coefficient
ρ between any pair of genes and any pair of sample is 0. Thus, the data are
completely independent. (b) Gene expressions within sample are dependent: For
a given sample s, the correlation coefficient between any pair of genes is ρ but the
correlation coefficient between any pair of samples is 0. (c) Gene expressions within
genes are dependent: For a given gene j, the correlation coefficient between any pair
of samples is ρ but the correlation coefficient between any pair of genes is 0.
We simulated the mdFDR and average power using 1000 simulation runs. Our
nominal mdFDR level was taken to be α = 0.05. For comparison purposes, we
compared the proposed procedure with the Guo et al. (2010) procedure and variants
of the proposed procedure in which the mdFWER controlling procedures used in
Steps 2 and 3 of the algorithm are respectively, the Holm’s procedure (Holm, 1979),
the Hochberg’s procedure (Hochberg, 1988) and the Bonferroni procedure. Although
all five procedures control the mdFDR on average at 0.05, the power of our proposed
methodology is much higher compared to all four competing procedures both under
independence as well dependence structures considered in the simulation.
3.4.2 Results of The Simulation Study
Independence: We summarize the results of the simulation studies in Figure 3.1
for the independence case. The horizontal axis denotes the proportion of truly
differentially expressed genes on the array and the vertical axis denotes the average
mdFDR (left panel) and average power (right panel). As desired, all five procedures
control the mdFDR on average at α = 0.05. However, the proposed Dunnett based
procedure has highest power compared to all other methods.
Dependence within genes across groups. In this case the components Zsij,
i = 1, ..., p are dependent with Zsij ∼ N(µij, 1) and have a common correlation ρ =
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Figure 3.1 mdFDR (left), Average Power (right) with the proposed methodology
and three variants using Holm, Hochberg and Bonferroni procedures, respectively, in
Steps 2 and 3 along with Guo et al. (2010) procedure, under independence among
genes and within genes.
0.2, 0.5, 0.8. The results are summarized in Figures 3.2 - 3.4. All five procedures
control the mdFDR at less than α = 0.05. Once again, as in the case of independence,
the proposed method gains in power compared to the other methods.
Dependence among genes. We next considered the situation where gene expressions
are dependent among genes. For this simulation, the components Zsij, j = 1, ...,m
are dependent with Zsij ∼ N(µij, 1) and have a common correlation ρ = 0.2, 0.5, 0.8.
The results are summarized in Figures 3.5 - 3.7. Again, all five procedures control
the mdFDR at less than α = 0.05 and as in the case of independence, the proposed
method gains in power compared to the other methods.
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Figure 3.2 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.2)
within genes.
3.5 Results of Data Analysis
In this section, we present the results of the analysis done by applying the suggested
methodology to FGS gene expression data. We identified a total of 9553 probe sets
to be differentially expressed in at least one pairwise comparison (relative to the
normal myometrium) at mdFDR of 0.05. These 9553 probe sets map to 6286 genes.
The Venn diagram of the Differentially Expressed Genes (DEGs) by tumor size is in
Figure 3.8. Based on the 6286 genes, using the Ingenuity Pathway Analysis (IPA,
2000-2014 QIAGEN), we discovered a total 157 distinct enriched canonical pathways
at a false discovery rate of 0.05. The Venn diagram of the number of enriched
canonical pathways by tumor size is provided in Figure 3.9. It is not surprising
that a third of the DEGs and nearly 30% of all significantly enriched pathways are
common to tumors of all sizes since tumor tissues are fundamentally different from
the normal myometrium. However, we discover several DEGs and pathways that are
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Figure 3.3 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.5)
within genes.
uniquely enhanced according to the tumor size, suggesting that changes in molecular
characteristics might be taking place as tumors grow.
Growth factors, vascularization and related pathways : The Netrin signaling
pathway is well-known as a versatile pathway with multiple functions. One of its
functions is to promote vascular networks and branching of blood vessels (Lejmi
et al., 2008) and angiogenesis (Epting et al., 2010). According to our analysis this
pathway is uniquely enriched in small tumors only, which suggests that perhaps
it is only necessary during the initial stages of tumor onset. The Interleukin-1
(IL-1) pathway is known to induce inflammatory response and the production of
prostaglandins and expression of IL-2 which may play a critical role in the fibroid
initiation and early development. For example, prostaglandins play a critical role
in the promotion of growth factors involved in angiogenesis, such as VEGF, basic
fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) (Jabbour
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Figure 3.4 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.8)
within genes.
et al., 2006) and development of fibroid requires vascularization and blood supply.
Thus, Interleukin-1 (IL-1) pathway likely plays an important role during the initial
stages of fibroid development. Interestingly, according to our analysis, this pathway
is uniquely enriched in small size tumors but not in the medium or large tumors.
Furthermore, the fibroblast growth factors 8 and 20 (FGF8, FGF20) which belong to
the Regulation of the Epithelial-Mesenchymal Transition Pathway and are well-known
to be involved in vascularization and angiogenesis, are both uniquely down-regulated
in small tumors and not differentially expressed in medium or large tumors. Our
analysis further implies that the Epithelial-Mesenchymal Transition Pathway was
enriched only in small and medium size tumors.
According to Ciarmela et al. (2011), estrogen may promote fibroid growth
through up-regulation of epidermal growth factor receptor (EGFR). However, we
found EGFR to be down-regulated in fibroids and that too only in the medium
48
Figure 3.5 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.2)
among genes.
size tumors. Similarly, the fibroblast growth factors (FGF) (acidic and basic)
were differentially expressed only in the medium size tumors. The acidic FGF
was up-regulated whereas the basic FGF was down regulated. These findings are
consistent with Ciarmela et al. (2011) (and references therein, e.g. (Wolanska et al.,
2008)) in that they are expressed during tumor progression. Similarly, insulin like
growth factor (IGF1) was only differentially expressed (up-regulated) in medium
size tumors. Additionally, growth factor signaling pathways such as VEGF, PDGF,
TGFβ and EGF are uniquely enriched in medium size tumors and not in small or
large tumors. While the above results suggest that some growth factors and related
pathways are very specific to small and medium tumors i.e. play an important role
during the early stages of tumor onset and growth, we discovered several growth
factors to be differentially expressed in tumors of all sizes. These included, insulin like
growth factor 2 (INS-IGF2), insulin like growth factor binding protein 5 (IGFBP5),
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Figure 3.6 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.5)
among genes.
and platelet derived growth factor C (PDGFC) which were up-regulated whereas
insulin-like growth factor binding protein 6 (IGFBP6), connective tissue growth factor
(CTGF), heparin-binding EGF-like growth factor (HBEGF), transforming growth
factor beta receptor II (TGFBR2), fibroblast growth factors 12 and 13 (FGF12,
FGF13) were down-regulated. Similarly, growth factor signaling pathways such as
the human growth factor (HGF) and IGF-1 were enriched in tumors of all sizes.
Thus, it appears that the differential expression of these genes and the enrichment of
the above pathways is necessary for tumor onset and progression.
Estrogen and related genes : Fibroids are hormonally mediated and it is
also well documented in the literature that accordingly estrogen and progesterone
receptors and prostaglandins promote proliferation of fibroids (see (Davis et al.,
2013; Talaulikar and Manyonda, 2012)). Not surprisingly, we found the estrogen
receptor ESR-1 to be up-regulated in tumors of all sizes. Interestingly, the
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Figure 3.7 mdFDR, Average Power with Dunnett screening and different mdFWER
controlling procedures compared to Guo et al. (2010), under dependence (ρ = 0.8)
among genes.
progesterone receptor (PGR) was up-regulated in only medium size tumors and
not differentially expressed in small or large tumors. This suggests that perhaps
PGR may not be involved in tumor initiation (i.e. small tumors) but is only
involved in growth of the tumor. However, its function ends once the tumor becomes
large enough. Most prostaglandins were generally down-regulated in tumors of all
sizes. For example, prostaglandin E receptor 3 (PTGER3), prostaglandin F receptor
(PTGFR) and prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase
and cyclooxygenase) (PTGS2) are down-regulated in tumor of all sizes. However,
some prostaglandins were differentially expressed according to the size of the tumor.
For example, prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase
and cyclooxygenase) (PTGS1) was differentially expressed only in the medium sized
tumors where it was down-regulated and prostaglandin E synthase 2 (PTGES2) was
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Figure 3.8 Venn diagrams of differentially expressed genes by tumor size.
Figure 3.9 Venn diagram of enriched pathways by tumor size.
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down-regulated in large tumors only but prostaglandin E receptor 4 (PTGER4) was
down-regulated in both medium and large tumors.
Similar to estrogen and progesterone receptors, the α and γ isoforms of
peroxisome proliferator-activated (PPAR) receptors have been associated with the
regulation of proliferation of uterine fibroids (Houston et al., 2003; Nam et al., 2007).
In our data both these isoforms are down-regulated in all tumor sizes compared to
the normal myometrium. We also discovered the related retinoid X receptor gamma
to be down-regulated in the medium size tumors but was not significant in small or
large tumors.
Collagens : There is a vast amount of literature implicating collagens to
smooth muscle tumors such as the fibroids (see (Davis et al., 2013), and references
therein). Consequently, it is not surprising that several collagens (COL1A1, COL1A2,
COL3A1, COL4A1-COL4A4, COL5A2, COL6A3, COL7A1, COL9A2, COL21A1,
COL22A1, COL27A1) and extra cellular matrix proteins are differentially expressed
in tumors of all sizes. Apart from COL4A3, COL4A4 and COL21A1, which were
down-regulated in all tumor size groups, the remaining 11 collagens were up-regulated
in tumor samples.
Other genes : Leptin receptor is well-known to be negatively associated with the
obesity and obesity is a potential risk factor for fibroids. Interestingly, we discover
leptin receptor (LEPR) to be significantly down-reglated in all tumor sizes. As noted
earlier, Diaz et al. (Diaz et al., 2005) demonstrated that β4 integrin had an increased
expression in larger breast tumors and in higher tumor grades. In our fibroid data,
however, we notice a down-regulation in β4 integrin in medium and large tumors and
was not differentially expressed in small tumors.
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3.6 Discussion and Conclusion
In this chapter, we offer a statistical methodology for conducting pairwise comparisons
in high dimensional data that is broadly applicable to a wide range of genomic data
including gene expression microarray data, CpG methylation data, RNA-seq data
and others. The proposed methodology not only controls the false discoveries made
when making several pairwise comparisons on the basis of high dimensional data,
but it controls for directional errors. Although in our algorithm we used Dunnett’s
procedure in Step 1 to derive the screening p-values, and again Dunnett’s procedure
in Step 2 to derive the pairwise p-values, they can be replaced by several other
procedures in the general procedure and the resulting method will continue to control
the mdFDR.
In the simulation studies we see that mdFDR is controlled for all the discussed
procedures under independence of test statistics and also under dependence within
and across genes. The proposed methodology based on the Dunnett test works best
among all the procedures in terms of average power.
Using our methodology we gain deeper insights into molecular characteristics of
uterine fibroids according to the tumor size. We have identified several differentially
expressed genes and pathways that are specifically enriched according to the tumor
size (or stage of growth). While researchers and clinicians who study fibroids are well
aware of many of the genes and pathways described in this chapter, we have provided
a characterization of these genes and pathways according to the tumor stage. Our
data can be further mined to gain deeper insights regarding fibroids.
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CHAPTER 4
CONTROL OF DIRECTIONAL ERRORS IN FIXED SEQUENCE
MULTIPLE TESTING
4.1 Introduction
Directional errors or Type III errors occur in testing situations with two-sided
alternatives when rejections are accompanied by additional directional claims. For
example, when testing a null hypothesis θ = 0 against θ 6= 0, rejection of the null
hypothesis is often augmented with the decision of whether θ > 0 or θ < 0. In case of
testing of a single hypothesis, Type III error or a Directional error is automatically
controlled at level α when the Type I error is controlled at the level α. However
in the case of simultaneously testing multiple hypotheses, it is often not known
whether additional directional decisions can be made without losing control of the
mixed directional familywise error rate (mdFWER), the probability of at least one
Type I or Type III error. Some methods have been developed in the literature by
augmenting additional directional decisions to the existing p-value based stepwise
procedures. Shaffer (1980) showed that Holm’s procedure (Holm, 1979), augmented
with decisions on direction based on the values of test statistics, can strongly control
mdFWER under the assumption that the test statistics are independent and under
specified conditions on the marginal distributions of the test statistics, but she also
showed that counterexamples exist even with two hypotheses. Finner (1994) and
Liu (1997) independently proved the same result for Hochberg procedure (Hochberg,
1988). Finner (1999) generalized the result of Shaffer (1980) to a large class of stepwise
or closed multiple test procedures under the same assumptions. Some recent results
have been obtained in Guo and Romano (2015).
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For control of the usual familywise error rate (FWER) (which does not
account for the possibility of additional Type III errors), the conventional fixed
sequence multiple testing procedure that strongly controls the FWER under arbitrary
dependence, is known to be a powerful procedure in testing situations with
pre-ordered hypotheses (Maurer et al., 1995; Wiens, 2003; Wiens and Dmitrienko,
2005). For reviews on recent relevant developments of fixed sequence multiple testing
procedures, see Dmitrienko, Tamhane and Bretz (2009) and Dmitrienko et al. (2013).
Indeed, suppose null hypotheses H1, . . . , Hn are pre-ordered, so that Hi+1 is tested
only if H1, . . . , Hi have all been rejected. The probability mechanism generating the
data is P and Hi asserts that P ∈ ωi, some family of data generating distributions. In
such case, it is easy to see that each Hi can be tested at level α in order to control the
FWER at level α, so that no adjustment for multiplicity is required. The argument
is simple and goes as follows. Fix any given P such that at least one Hi is true (or
otherwise the FWER is 0 anyway). If H1 is true, i.e. P ∈ ω1, then a Type I error
occurs if and only if H1 is rejected, and so the FWER is just the probability that H1
is rejected, which is assumed controlled at level α when testing H1. If H1 is false, just
let f be the smallest index corresponding to a true null hypothesis, i.e. Hf is true
but H1, . . . , Hf−1 are all false. In this case, a Type I error occurs if and only if Hf is
rejected, which is assumed to be controlled at level α.
In fact, in situations where ordering is not specified, the above result suggests
it may be worthwhile to think about hypotheses in order of importance so that
potentially false hypotheses are more easily detected. Indeed, as is well-known, when
the number n of tested hypotheses is large, control of the FWER is often so stringent
that often no rejections can be detected, largely due to the multiplicity of tests and the
need to find significance at very low levels (as required, for example, in the Bonferroni
method with n large). On the other hand, under a specified ordering, each test is
carried out at the same conventional level.
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To our knowledge, no one explores the possibility of making additional direc-
tional decisions for such fixed sequence procedures. In this chapter, we introduce such
fixed sequence procedures augmented with additional directional decisions and discuss
its mdFWER control under independence and some dependence. For such directional
procedures, its simple fixed sequence structure of the tested hypotheses makes the
notoriously challenging problem of controlling the mdFWER under dependence a
little easier to handle than stepwise procedures.
The rest of the chapter is organized as follows. Section 4.2 introduces the
basic notations and concepts used in this project. In Section 4.3 we discuss
mdFWER control under arbitrary dependence. In Section 4.4 we discuss control
of mdFWER under independence of test statistics. These results are extended to
positive dependence in Sections 4.5 and 4.6. Finally, in Section 4.7 we summarize
the results presented in this chapter. The proofs of all the theorems and lemmas
presented in this chapter are given in Appendix A.
4.2 Preliminaries
In this section we present the notations and a few assumptions used in this chapter.
We consider the problem of testing n two-sided hypotheses, H1, H2, ..., Hn specified
as follows:
Hi : θi = 0 vs. H
′
i : θi 6= 0, i = 1, 2, ..., n. (4.1)
We assume the hypotheses are ordered in advance, either using some prior knowledge
about the importance of the hypotheses or by some other specified criteria, so that
H1 is tested first and Hi is only tested if H1, . . . , Hi−1 are all rejected. We also assume
that, for each i, a test statistic Ti and p-value Pi are available to test Hi (as a single
test). For a rejected hypothesis Hi, we decide on the sign of the parameter θi by the
sign of the corresponding test statistic, i.e., we conclude θi > 0 if Ti > 0 and vice
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versa. The errors that might occur while testing these hypotheses are: Type I and
Type III errors. A Type I error occurs when a true Hi is falsely rejected. A Type III
error occurs when a false Hi is correctly rejected but claimed sign of the parameter
is wrong. Then, the mdFWER is the probability of making at least a Type I or Type
III error, and it is desired that this error rate is no bigger than α for all possible data
generating distributions in the model.
We make a few standard assumptions about the test statistics. Let Ti ∼ Fθi(·)
for some continuous cumulative distribution function Fθi(·) having parameter θi. In
general, most of our results also apply through the same arguments when the family
of distributions of Ti depends on i, though for simplicity of notation, the notation is
suppressed. We assume that F0 is symmetric about 0, Fθi is stochastically increasing
in θi. For testing Hi vs. H
′
i , rejections are based on large values of |Ti| and the
corresponding two-sided p-value is defined by,
Pi = 2 min{F0(Ti), 1− F0(Ti)}, i = 1, . . . , n. (4.2)
We assume that the P -values are distributed as Uniform(0,1) when θi = 0. Various
dependence assumptions between the test statistics are used throughout this chapter.
4.3 The mdFWER Control Under Arbitrary Dependence
A general fixed sequence procedure based on marginal p-values must specify the
critical level αi that is used for testing Hi, in order for the resulting procedure to
control the mdFWER at level α. When controlling the FWER without regard to
Type III errors, each αi can be as large as α. However, Theorem 4.1 below shows
that by using the critical constant αi = α/2
i−1, the mdFWER is controlled at level
α. Moreover, we show that these critical constants are not improvable. Formally, the
optimal procedure is defined as follows.
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Procedure 4.1 (Directional fixed sequence procedure under arbitrary
dependence).
• Step 1: If P1 ≤ α then reject H1 and continue to test H2 after making directional
decision on θ1: conclude θ1 > 0 if T1 > 0 or θ1 < 0 if T1 < 0. Otherwise, accept
all the hypotheses and stop.
• Step i: If Pi ≤ α/2i−1 then reject Hi and continue to test Hi+1 after making
directional decision on θi: conclude θi > 0 if Ti > 0 or θi < 0 if Ti < 0.
Otherwise, accept the remaining hypotheses Hi, . . . , Hn.
In the following, we discuss the mdFWER control of Procedure 4.1 under
arbitrary dependence of the p-values. When testing a single hypothesis, the mdFWER
of Procedure 4.1 reduces to the Type I or Type III error rate depending on whether
θ = 0 or θ 6= 0, and Procedure 4.1 reduces to the usual p-value based method along
with the directional decision for the two-sided test. The following lemma covers this
case.
Lemma 4.1. Consider testing the single hypothesis H : θ = 0 against H
′
: θ 6= 0 at
level α, using the usual p-value based method along with a directional decision. If H
is a false null hypothesis, then the Type III error rate is bounded above by α/2.
Generally, when simultaneously testing n hypotheses, by using Lemma 4.1 and
mathematical induction, we have the following result holds.
Theorem 4.1. For Procedure 4.1 defined as above, the following conclusions hold.
(i) This procedure strongly controls the mdFWER at level α under arbitrary
dependence of the p-values.
(ii) One cannot increase even one of the critical constants αi = α/2
i−1, i = 1, . . . , n,
while keeping the remaining fixed without losing control of the mdFWER.
In fact, the proof shows that no strong parametric assumptions are required.
However, the rapid decrease in critical values α/2i−1 makes rejection of additional
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hypotheses difficult. Thus, it is of interest to explore how dependence assumptions can
be used to increase these critical constants while maintaining control of the mdFWER.
The assumptions and methods will be described in the remaining sections.
Remark 4.1. Instead of Procedure 4.1, let us consider the conventional fixed sequence
procedure with the same critical constant α augmented with additional directional
decisions, which is defined in Section 4.4 as Procedure 4.2. By using Bonferroni
inequality and Lemma 4.1, we can prove that the mdFWER of this procedure is
bounded above by n+1
2
α. Thus, the modified version of the procedure, which has the
same critical constant 2α
n+1
, strongly controls the mdFWER at level α under arbitrary
dependence of p-values. However, it is unclear if such critical constant can be further
improved without losing the control of the mdFWER.
4.4 The mdFWER Control Under Independence
We further make the following assumptions on the distribution of the test statistics.
Assumption 4.1 (Independence). The test statistics, T1, . . . , Tn, are mutually
independent.
Of course, it follows that the p-values P1, . . . , Pn are mutually independent as
well.
As will be seen, it will be necessary to make further assumptions on the family
of distributions for each marginal test statistic.
Definition 4.1 (Monotone Likelihood Ratio (MLR)). A family of probability
density functions fδ(·) is said to have monotone likelihood ratio property if, for any
two values of the parameter δ, δ2 > δ1 and any two points x2 > x1,
fδ2(x2)
fδ1(x2)
≥ fδ2(x1)
fδ1(x1)
, (4.3)
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or equivalently,
fδ1(x1)
fδ1(x2)
≥ fδ2(x1)
fδ2(x2)
. (4.4)
Definition 1 means that, for fixed x1 < x2, the ratio
fδ(x1)
fδ(x2)
is non-increasing in
δ. Two direct implications of Definition 1 in terms of the cdf Fδ(·) are
Fδ1(x2)
Fδ1(x1)
≤ Fδ2(x2)
Fδ2(x1)
, (4.5)
and
1− Fδ1(x2)
1− Fδ1(x1)
≤ 1− Fδ2(x2)
1− Fδ2(x1)
. (4.6)
Assumption 4.2 (MLR Assumption). The family of marginal distributions of the
Ti has monotone likelihood ratio.
Based on the conventional fixed sequence multiple testing procedure, we define
a directional fixed sequence procedure as follows, which is the conventional fixed
sequence procedure augmented with directional decisions. In other words, any
hypothesis is tested at level α, and as will be seen under the specified conditions,
no reduction in critical values is necessary in order to achieve mdFWER control.
Procedure 4.2 (Directional Fixed Sequence Procedure).
• Step 1: If P1 ≤ α, then reject H1 and continue to test H2 after making a
directional decision on θ1: conclude θ1 > 0 if T1 > 0 or θ1 < 0 if T1 < 0.
Otherwise, accept all the hypotheses and stop.
• Step i: If Pi ≤ α , then reject Hi and continue to test Hi+1 after making a
directional decision on θi: conclude θi > 0 if Ti > 0 or θi < 0 if Ti < 0.
Otherwise, accept the remaining hypotheses, Hi, . . . , Hn.
For Procedure 4.2, in the case of n = 2, we derive a simple expression for the
mdFWER in Lemma 4.2 below and prove its mdFWER control in Lemma 4.3 by
using such simple expression.
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Lemma 4.2. Consider testing two hypotheses H1 : θ1 = 0 and H2 : θ2 = 0, against
both sided alternatives, using Procedure 4.2 at level α. Let c1 = F
−1
0 (α/2) and c2 =
F−10 (1− α/2). When θ2 = 0, the following result holds.
mdFWER =
 α + Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c2, c2)− F(θ1,0)(c2, c1) if θ1 > 01 + Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c1, c1)− F(θ1,0)(c1, c2) if θ1 < 0.
(4.7)
In the above, Fθ1,θ2(·, ·) refers to the joint c.d.f. of (T1, T2). Then, under Assumption
4.1 (independence), (4.7) can be simplified as
mdFWER =
 α + Fθ1(c1)− αFθ1(c2) if θ1 > 01 + αFθ1(c1)− Fθ1(c2) if θ1 < 0. (4.8)
Lemma 4.3. Under Assumption 4.1 (independence) and Assumption 4.2 (MLR),
Procedure 4.2 strongly controls the mdFWER when n = 2.
Generally, for testing any n hypotheses, by using mathematical induction and
Lemma 4.3, we also prove the mdFWER control of Procedure 4.2 under the same
assumptions as in the case of n = 2.
Theorem 4.2. Under Assumption 4.1 (independence) and Assumption 4.2 (MLR),
Procedure 4.2 strongly controls the mdFWER at level α.
Many families of distributions have the MLR property: normal, uniform,
logistic, Laplace, Student’s t, generalized extreme value, exponential families of
distributions, etc. However, it is also important to know whether or not the above
results fail without the MLR assumption. A natural family of distributions to
consider without the MLR property is the Cauchy family; indeed, Shaffer (1980)
used this family to obtain a counterexample for the directional Holm procedure
while testing p-value ordered hypotheses. We now show that Procedure 4.2 fails
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to control the mdFWER for this family of distributions with corresponding cdf
Fθ(x) = 0.5 +
1
pi
arctan(x− θ), even under independence.
Lemma 4.2 can be used to verify the calculation for the case of n = 2 with
θ1 > 0 and θ2 = 0; specifically, see (4.8). Indeed, we just need to show,
Fθ1(−c) = F0(−c− θ1) > αFθ1(c) = αF0(c− θ1) , (4.9)
where c is the 1−α/2 quantile of the standard Cauchy distribution, given by tan[pi(1−
α)/2]. Take α = 0.05, so c = 12.7062. Then, the above inequality (4.9) is violated
for example by θ1 = 100. The left side is approximately F (−112.7) ≈ 0.002824 while
the right side is
0.05× F (−87.3) = 0.05× 0.0036 = 0.00018.
4.5 Extension to Positive Dependence
Clearly, the assumption of independence is of limited utility in multiple testing, as
many tests are usually carried out on the same data set. Thus, it is important to
generalize the results of the previous section to cover some more general cases. As
is typical in the multiple testing literature (Benjamini and Yekutieli (2001); Sarkar
(2002); Sarkar and Guo (2010)), assumptions of positive regression dependence will
be used.
Before defining the assumptions, for convenience, we introduce several notations
below. Among the prior-ordered hypotheses H1, . . . , Hn, let i0 denote the index of
the first true null hypothesis, n1 denote the number of all false nulls,and Ti1 , . . . , Tin1
denote the corresponding false null test statistics. Specifically, if all Hi’s are false, let
i0 = n+ 1.
Assumption 4.3. The false null test statistics along with parameters, θi1Ti1 , . . . , θin1Tin1 ,
are positively regression dependent in the sense of
E
{
φ(θi1Ti1 , . . . , θin1Tin1 ) | θikTik ≥ u
} ↑ u,
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for each θikTik and any (coordinate-wise) non-decreasing function φ.
Assumption 4.4. The first true null statistic, Ti0, is independent of all false null
statistics Tik , k = 1, . . . , n1 with ik < i0.
Theorem 4.3. Under Assumptions 4.2 - 4.4, Procedure 4.2 strongly controls the
mdFWER at level α.
Corollary 4.1. When all tested hypotheses are false, Procedure 4.2 strongly controls
the mdFWER at level α under Assumptions 4.2 - 4.3.
Remark 4.2. In Theorem 4.3, we note that specifically, when all of the tested
hypotheses are false, Assumption 4.4 is automatically satisfied. Generally, consider
the case of any combination of true and false null hypotheses where Assumption 4.4 is
not imposed. Without loss of generality, suppose θi > 0, i = 1, . . . , n− 1 and θn = 0,
that is, the first n−1 hypotheses are false and the last one is true. Under Assumptions
4.2-4.3, if Tn (or −Tn) and T1, . . . , Tn−1 are positively regression dependent, then the
mdFWER of Procedure 4.2 when testing H1, . . . , Hn is, for any n, bounded above by
Pr(make at least one Type III error when testing H1, . . . , Hn−1 or Tn /∈ (c1, c2))
≤ lim
θn→0+
Pr(make at least one Type III error when testing H1, . . . , Hn)
+ lim
θn→0+
Pr(Tn ≥ c2)
≤ α + α/2 = 3α/2.
The first inequality follows from the fact that when θn → 0+, Hn can be interpreted
as a false null hypothesis with θn > 0, and thus, one Type III error is made if Hn is
rejected and Tn ≤ c1. The second inequality follows from Corollary 4.1 and Lemma
4.1.
Based on the above inequality, a modified version of Procedure 4.2, the
directional fixed sequence procedure with the critical constant 2α/3, strongly controls
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the mdFWER at level α under Assumptions 4.2-4.3 and the above additional
assumption.
Remark 4.3. In the above remark, further, if we do not make any assumption
regarding dependence between the true null statistic Tn and the false null statistics
T1, . . . , Tn−1. Then, by Theorem 4.3, the mdFWER of Procedure 4.2 when testing
H1, . . . , Hn is bounded above by,
Pr( make at least one Type III error when testing H1, . . . , Hn−1)
+ Pr( make Type I error when testing Hn)
≤ α + α = 2α.
Therefore, an alternative modified version of Procedure 4.2, the directional fixed
sequence procedure with the critical constant α/2, strongly controls the mdFWER
at level α only under Assumptions 4.2-4.3.
4.6 Further Extensions to Positive Dependence
We now develop alternative results to show that Procedure 4.2 can control mdFWER
even under certain dependence between the false null and true null statistics. We
relax the assumption of independence that the false null statistics are independent of
the first true null statistic, and consider a slightly strong version of the conventional
positive regression dependence on subset of true null statistics (PRDS) (Benjamini
and Yekutieli, 2001), which is given below.
Assumption 4.5. The false null test statistics, T1, . . . , Ti0−1 and the first true null
statistic Ti0, are positive regression dependent in the sense of
E {φ(T1, . . . , Ti0−1) | Ti0 ≥ u, T1, . . . , Tj} ↑ u, (4.10)
for any given j = 1, . . . , i0−1, any given values of T1, . . . , Tj and any (coordinate-wise)
non-decreasing function φ.
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We firstly consider the case of n = 2, that is, while testing two hypotheses, and
show control of the mdFWER of Procedure 4.2 when the test statistics are positively
regression dependent in the sense of Assumption 4.5.
Proposition 4.1. Under Assumptions 4.2 and 4.5, the mdFWER of Procedure 4.2
is strongly controlled at level α when n = 2.
Specifically, in the case of bivariate normal distribution, Assumption 4.2 is
satisfied and two test statistics T1 and T2 are always positively or negatively regression
dependent. As in the proof of Proposition 4.1, to show the mdFWER control of
Procedure 4.2, we only need to consider the case of θ1 6= 0 and θ2 = 0. Thus, if
T1 and T2 are negatively regression dependent, we can choose −T2 as the statistic
for testing H2 and Assumption 4.5 is still satisfied. By Proposition 4.1, we have the
following corollary holds.
Corollary 4.2. Under the case of bivariate normal distribution, the mdFWER of
Procedure 4.2 is strongly controlled at level α when n = 2.
We now consider the case of three hypotheses. The general case will ultimately
be considered, but is instructive to discuss the case separately due to the added
multivariate MLR condition, which is described as follows.
Let f(x|T1) and g(x|T1) denote the probability density functions of T2 and T3
conditional on T1, respectively.
Assumption 4.6 (Bivariate Monotone Likelihood Ratio (BMLR)). For any
given value of T1, f(x|T1) and g(x|T1) have the monotone likelihood ratio (MLR)
property in x, i.e., for any x2 > x1, we have
f(x2|T1)
g(x2|T1) ≥
f(x1|T1)
g(x1|T1) . (4.11)
Proposition 4.2. Under Assumptions 4.2, 4.3, 4.5, and 4.6, the mdFWER of
Procedure 4.2 is strongly controlled at level α when n = 3.
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Remark 4.4. In the case of three hypotheses, suppose that the test statistics
Ti, i = 1, . . . , 3 are trivariate normally distributed with the mean θi. Without loss
of generality, assume θi > 0, i = 1, 2 and θ3 = 0, that is, H1 and H2 are false and
H3 is true. Let Σ = (σij), i, j = 1, . . . , 3, denote the variance-covariance matrix of
Ti’s. It is easy to see that Assumption 4.2 is always satisfied. Also, when σij ≥ 0 for
i 6= j, Assumption 4.3 and Assumption 4.5 are satisfied. Finally, when σ22 = σ33 and
σ12 = σ13, Assumption 4.6 is satisfied.
Finally, we consider the general case of n hypotheses. Now we must consider the
multivariate monotone likelihood ratio property, described as follows. For any given
j = 1, . . . , i0 − 1, let f(x|T1, . . . , Tj−1) and g(x|T1, . . . , Tj−1) denote the probability
density functions of Tj and Ti0 conditional on T1, . . . , Tj−1, respectively.
Assumption 4.7 (Multivariate Monotone Likelihood Ratio (MMLR)). For
any given values of T1, . . . , Tj−1, f(x|T1, . . . , Tj−1) and g(x|T1, . . . , Tj−1) have the
monotone likelihood ratio (MLR) property in x, i.e., for any x2 > x1, we have
f(x2|T1, . . . , Tj−1)
g(x2|T1, . . . , Tj−1) ≥
f(x1|T1, . . . , Tj−1)
g(x1|T1, . . . , Tj−1) . (4.12)
Theorem 4.4. Under Assumptions 4.2, 4.3, 4.5, and 4.7, the mdFWER of Procedure
4.2 is strongly controlled at level α.
4.7 Conclusions
In this chapter, we consider the problem of simultaneously testing multiple prior-
ordered hypotheses accompanied by directional decisions. The conventional fixed
sequence procedure augmented with additional directional decisions are proved to
control the mdFWER under independence and some dependence, whereas, this
procedure is also shown to be far too liberal to control the mdFWER, if no dependence
assumptions are imposed on the test statistics. We hope that the approaches and
techniques developed in this chapter will also shed some light on attacking the
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notoriously challenging problem of controlling the mdFWER under dependence for
p-value ordered stepwise procedures.
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CHAPTER 5
FDR CONTROLLING PROCEDURES FOR TESTING A-PRIORI
ORDERED HYPOTHESES
5.1 Introduction
In large scale multiple testing problems in applications such as stream data, statistical
process control, etc., the tested hypotheses are ordered a-priori by time and it is
desired to control False Discovery Rate (FDR) while making real-time decisions about
rejecting or accepting a hypothesis and requiring to test all the hypotheses in the
sequence irrespective of the number of prior acceptances.
A main feature of the data in these applications is that the data is not static and
has a natural hierarchy in the data points that evolve over time and at any instance
we only have the information up till that instance. This incomplete information
implies that we do not have all the p-values available at the time. This presents
several challenges in the development of multiple testing methodology. The existing
FDR controlling procedures, such as the Benjamini-Hochberg procedure or any other
stepwise procedures have an inherent assumption that all the p-values are available at
hand before the method is applied. As a result, these procedures are unable to make
real time decisions based on the incomplete information pertaining to the p-values.
A few researchers did some work in the control of FDR in the context of
hierarchically ordered hypotheses. Farcomeni and Finos (2013) developed an FDR
controlling procedure based on a data-driven ordering of hypotheses where hypotheses
are tested until a suitable number are not rejected. Lynch et al. (2014) introduced an
FDR controlling procedure in fixed sequence multiple testing which allows more than
one acceptance in the fixed sequence testing of hypotheses. Though these procedures
incorporate the hierarchy of hypotheses while controlling FDR, they do not allow
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testing of each and every hypothesis in the sequence. This motivates us to our goal
to develop procedures that exploit the natural hierarchy in the data and control FDR
while making real time decisions. In the FWER framework, Wiens (2003) and Wiens
and Dmitrienko (2005) developed the Fallback procedure that allows testing of all
hypotheses in a sequence, by awarding the later critical constant in case of rejection
of a hypothesis. Borrowing the idea from this procedure we develop procedures in the
FDR control framework that are suitable for applications requiring real-time decision
making.
The rest of the chapter is organized as follows: In Section 5.2, we describe some
motivating examples for this research. In Section 5.3, we discuss the unique structure
of hypotheses in these applications. We present the proposed methods in Section 5.4.
We present a simulation study in Section 5.5 and conclusions in Section 5.6.
5.2 Motivating Examples
A data stream is a sequence of continuously arriving data points obtained as a
result of a continuous data generation process that might evolve over time. Some
examples are cellular network monitoring data, computer network monitoring data,
web click-stream data, readings from stock quotes, etc. Very Often, the stream data
is analyzed to detect any problems or failures appearing in the generation process
and critical decisions are made based on the information provided by data stream.
In such situations it becomes important to ensure that the number of false alarms is
statistically controlled at a fixed level, not to overwhelm the users. Take the example
of data collected from a cellular network. Here, data points arrive continuously that
carry information on attributes like a call connection problem, voice quality problem,
data connection failure, etc. These anomalous data points are formed into clusters
based on several characteristics, for example, their geographical vicinity. These
clusters give an indication of problems at a transmission tower in the corresponding
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area. The problem is to identify whether a cluster so formed indicates the need for
immediate action to be taken at the corresponding transmission tower, that is, we
need to identify whether the cluster is an outlier or not.
Statistical Process Control (SPC) is the branch of Statistics that deals with
methods applied to a continuous process, say, manufacturing lines, in order to monitor
and control the process. This ensures that the process operates at its full potential
and can make as much conforming product as possible with a minimum of waste. SPC
emphasizes early detection and prevention of problems, rather than the correction of
problems after they have occurred. This requires testing of hypotheses at regular
intervals of time while making real time decisions on whether a process is out of
control at the time of testing or not. This needs to be handled by an appropriate
multiple testing methodology to restrict the error of not identifying the process to be
out of control.
These applications motivate us to develop multiple testing methods that can
be used to identify anomalous clusters or identifying whether the process is out of
control or not, while controlling an appropriate rate of false positives.
5.3 Structure of Hypotheses
As seen in the motivating examples, the hypotheses tested in a sequence in the
applications have a very unique structure which is not typically discussed in the
existing multiple testing procedures. In most of the multiple testing procedures the
testing sequence is such that most of the false null hypotheses occur ahead of the true
null hypotheses. This sequence is achieved in the stepwise procedures through p-value
ordering. In fixed sequence multiple testing, the order of the hypotheses is fixed based
on their relative importance and as a result it is practical to assume that most of the
false null hypotheses occur before the true null hypotheses in the sequence. But this
is not true in the case of stream data or SPC. The monitoring of the underlying data
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generation process is done in real time and the hypotheses tested do not usually have
any structure in the occurrence of true null or false null hypothesis.
At any given instance, the purpose is to test whether a process is out of control
or not. A scientist, who is monitoring the process, chooses the method to obtain the
test statistic and p-value to test the null and alternative hypotheses of the following
sort:
H : The underlying process is in control
vs.
H ′ : The underlying process is out of control.
Whenever the null hypothesis is rejected, remedial measures are immediately
taken to rectify the situation and make the process “in control” again. As a result,
we expect to see very few false null hypotheses in the testing sequence. The only
assumption we can make here is that the probability of a null hypothesis being false
is very low. This kind of structure is unique and needs new procedures for multiplicity
adjustment.
5.4 Procedures for Testing a-priori Ordered Hypotheses
In this section we present the procedures we develop for testing a-priori ordered
hypotheses that allow testing of all the hypotheses while utilizing the partial
information available at the time of testing a hypothesis and controlling FDR.
In the framework of FWER control, Wiens (2003)’s Fallback procedure and Qiu
et al. (2014) Generalized Fixed Sequence Procedure A1 allow testing of all the
hypotheses in a sequence while strongly controlling FWER. Motivated by the idea of
awarding the critical constants on rejection of a null hypothesis, that is showcased in
these procedures for controlling FWER, we develop FDR controlling procedures for
applications that require real time decision making.
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Suppose, H1, H2, . . . , Hm are m null hypotheses ordered a-priori in time.
Let, P1, P2, . . . , Pm be the p-values for testing the a-priori ordered hypotheses. A
conventional method for controlling FDR while testing a-priori ordered hypotheses
can be defined as follows:
Definition 5.1 (Conventional Method for a-priori Ordered Hypotheses).
Define the critical constants, δ1, . . . , δm. Reject Hi if Pi ≤ δi, for i = 1, . . . ,m.
5.4.1 Fallback-Type Procedure under PRDS
Let, ω1, ω2, . . . , ωm denote the series of weights such that
∑m
i=1 ωi = 1. Let Ri denote
the number of hypotheses rejected before Hi is tested. Note that Ri is a random
variable and R1 = 0 with probability 1.
Assumption 5.1 (PRDS Property). The vector of p-values P = (P1, . . . , Pm), is
said to be positive regression dependent on a subset (PRDS) I0 if,
Pr (P ∈ C|Pi)↗ in Pi (5.1)
for each i ∈ I0, for any increasing set C and vice versa.
Procedure 5.1 (Fallback-Type Method for controlling FDR under PRDS).
Step 1: Set, α1 = ω1α. Reject H1 if P1 ≤ α1.
Step 2, . . . , m : If Hi−1 is rejected, then set αi = ωiα+αi−1; otherwise, set αi = ωiα.
Reject Hi if Pi ≤
(
1 + Ri
m−i+1
)
αi.
Theorem 5.1. Under Assumption 5.1, Procedure 5.1 strongly controls FDR at level
α.
Proof Let, U denote the index of the first rejected true null hypothesis. Let, m0 out
of m hypotheses are true null and u1, u2, . . . , um0 denote the indices of the true null
hypotheses. Let, V denote the number of true null hypotheses rejected and S denote
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the number of false null hypotheses rejected. Then,
FDR = E
(
V
V + S
I {V > 0}
)
(5.2)
The event {V > 0} is equivalent to ∪m0i=1 {U = ui}. Thus,
FDR =
m0∑
i=1
E
(
V
V + S
I {U = ui}
)
(5.3)
Define,
α∗ui = α
ui∑
j=ui−1+1
ωj i = 1, . . . ,m0. (5.4)
Consider the event {U = ui}. This event means that first Type I error occurs by
rejecting the true null Hui . The first ui− 1 hypotheses are either false nulls (ui− i in
number) or accepted true nulls (i− 1 in number). Thus, {U = ui} implies,
V ≤ m− ui + 1
S ≥ Rui
Therefore,
V
V + S
≤ V
V +Rui
≤ m− ui + 1
m− ui + 1 +Rui
(5.5)
For each ui, define,
βr =
m− ui + 1 + r
m− ui + 1 αui , r = 0, . . . , ui − 1.
Then, for each ui we have,
E
(
V
V + S
I {U = ui}
)
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≤ E
(
m− ui + 1
m− ui + 1 +Rui
I (U = ui)
)
(5.6)
≤ E
(
m− ui + 1
m− ui + 1 +Rui
I (Pui ≤ ((m− ui + 1 +Rui)/(m− ui + 1))αui)
)
(5.7)
=
ui−1∑
r=0
E
(
m− ui + 1
m− ui + 1 + rI {Pui ≤ βr}
∣∣∣∣Rui = r) · Pr (Rui = r) (5.8)
The inequality in (5.6) follows due to (5.5). The inequality in (5.7) follows as
the event {U = ui} implies the event {Pui ≤ ((m− ui + 1 +Rui)/i(m− i+ 1))αui}.
(5.8) follows as Rui can only take values between 0 and ui − 1. Then (5.8) becomes,
=
ui−1∑
r=0
m− ui + 1
m− ui + 1 + rPr (Rui = r|Pui ≤ βr)Pr (Pui ≤ βr)
≤ αui
ui−1∑
r=0
Pr (Rui = r|Pui ≤ βr) (5.9)
= αui
ui−1∑
r=0
[Pr (Rui ≥ r|Pui ≤ βr)− Pr (Rui ≥ r + 1|Pui ≤ βr)]
= αuiPr (Rui ≥ 0|Pui ≤ β0)
+ αui
[
ui−1∑
r=1
{Pr (Rui ≥ r|Pui ≤ βr)− Pr (Rui ≥ r|Pui ≤ βr−1)}
]
≤ αui (5.10)
The inequality in (5.9) follows as the p-values are stochastically larger than the U(0, 1)
distribution. (5.10) follows by Assumption 5.1 and by noting that {Rui ≥ r} is a
decreasing set. Thus, finally we have,
FDR =
m0∑
i=1
E
(
V
V + S
I {U = ui}
)
≤
m0∑
i=1
αui ≤
m0∑
i=1
α∗ui ≤ α
m∑
i=1
ωi = α.
This shows strong control of FDR under PRDS assumption of the p-values. 
Remark 5.1. The critical constants in Procedure 5.1 are larger than the critical
constants of the conventional Fallback procedure, so the newly introduced procedure
is more powerful than the conventional Fallback procedure.
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Remark 5.2. The critical constants utilize the information available before the testing
the ith hypothesis by including the termRi, which is the number of hypotheses rejected
before Hi. Thus, the information at hand is utilized which in turn improves the power
of the procedure.
Remark 5.3. Note that the critical constants are increasing function of Ri, so it also
implies that the idea of the usual Fallback procedure for awarding the rejections is
utilized.
Optimality of the Procedure under PRDS: We look at a particular configu-
ration of p-values under PRDS and discuss the optimality of the critical constants of
the fallback type procedure by showing that the critical constants cannot be made
any larger, while keeping the others constant, without losing control of FDR. The
Fallback type procedure will be said to be optimal if it can strongly control FDR
with any set of weights ωi.
Let u1, u2, . . . , um0 denote the indices of the true null hypotheses in the sequence.
Let us consider a joint distribution of the p-values such that,
• All the false null hypotheses occur before the true null hypotheses.
• Each false null p-value is 0.
• The true null p-values, Pui ∼ U(0, 1) and Pui = p, i = 1, . . . ,m0.
Let us assume, the weights are such that ω1 ≥ ω2 ≥ · · · ≥ ωm, with,
∑u1
i=1 ωi = 1 and
ωu1+1 = · · · = ωm = 0.
Under such a joint distribution of p-values, for any u1, 1 ≤ u1 ≤ m, the first
u1 − 1 hypotheses are false nulls whose corresponding p-value is 0 with probability 1
and the remaining m0 = m − u1 + 1 hypotheses are true nulls. Thus, the sequence
of p-values for the a priori ordered hypotheses is, P = (0, . . . , 0, p, . . . , p). Note that
this sequence of p-values is positive regression dependent on a subset of the true null
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p-values because, for any increasing set D,
Pr (P ∈ D|Pui = p) =
 1 if (0, . . . , 0, p, . . . , p) ∈ D,0 otherwise. (5.11)
The FDR of the fallback type procedure, under this configuration is exactly,
= E
(
V
V + S
I (V > 0)
)
=
m− u1 + 1
m
· m
m− u1 + 1αu1
= α
u1∑
j=1
ωj. (5.12)
Then, the FDR is exactly = α and thus, the critical constant cannot be made any
larger without losing control of FDR.
Thus, we show optimality of Procedure 5.1 by showing a configuration where
even a single critical constant cannot be made larger, while keeping the others same,
without losing strong control of FDR.
5.4.2 Fallback-Type Procedure under Arbitrary Dependence
In this section, we discuss control of FDR under arbitrary dependence of the p-values.
We show that with an appropriate modification in the critical constants of Procedure
5.1, we can achieve FDR control under arbitrary dependence of the p-values.
Procedure 5.2 (Fallback-Type Method for controlling FDR under Arbitrary
Dependence).
Step 1: Set, α1 = ω1α. Reject H1 if P1 ≤ α1.
Step 2, . . . , m : If Hi−1 is rejected, then set αi = ωiα+αi−1; otherwise, set αi = ωiα.
Reject Hi if,
Pi ≤
(
1 +
Ri
m− i+ 1
)
αi
ci
,
where, ci = 1 +
∑i−1
k=1(1/(m− i+ 1 + k)), i = 2, . . . ,m.
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Theorem 5.2. Procedure 5.2 strongly controls FDR at level α under arbitrary
dependence of the p-values.
The proof of this theorem is provided in Appendix B.
Remark 5.4. The correction factors ci applied to the critical constants in Procedure
5.1 are very similar to the correction factor applied to the critical constants in the BH
procedure in Benjamini and Yekutieli (2001). Figure 5.1 compares the two correction
factors. Clearly, the correction factor of Procedure 5.2 is much smaller compared to
that of the BY procedure (Benjamini and Yekutieli, 2001).
Figure 5.1 Comparison of the correction factors used in our procedure in Theorem
5.2 and the BY procedure for m = 200 hypotheses.
5.4.3 FDR Control under Independence
We have already seen that the fallback-type procedure under arbitrary dependence
can be improved under the stronger condition of positive regression dependence of the
p-values. This motivates us to explore whether an even improved procedure can be
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obtained under independence of the p-values. In this section, we develop a procedure,
for FDR control while testing a-priori ordered hypotheses under the independence of
the p-values.
Procedure 5.3 (Method under Independence).
Define,
αi =
(Ri + 1)α
m− [α(m− i) + (1− α)Ri] , i = 1, . . . ,m, (5.13)
where, Ri is the number of hypotheses rejected before testing Hi.
If Pi ≤ αi then reject Hi, otherwise, accept Hi, i = 1, . . . ,m.
Note that, by definition, R1 = 0.
Theorem 5.3. Procedure 5.3 can strongly control FDR at level α if the p-values are
mutually independent.
The proof of this theorem is inspired by Lynch et al. (2014)’s proof of the FDR
control of the procedure allowing k acceptances under independence. Let us introduce
a few notations. For i = 1, . . . ,m, let Vi and Si, respectively denote the numbers of
false rejections and true rejections among the first i rejections and let Ji denote the
index of the ith rejected hypothesis. As defined in Lynch et al. (2014), if there are
less than i rejections, we define, Vi = Vi−1, Si = Si−1 and Ji = m+ 1. For notational
convenience, we define, V0 = S0 = J0 = 0, V0/0 = 0 and S0/0 = 1.
We use the Lemma 2.2 in Lynch et al. (2014), described below, to prove Theorem
5.3.
Lemma 5.1 (Lemma 2.2 in Lynch et al. (2014)).
The FDR of any fallback type method can be expressed as,
FDR = E
(
m∑
i=1
(
Vi
i
− Vi−1
i− 1
)
I{Ji < m+ 1}
)
. (5.14)
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We now present the proof of Theorem 5.3 which is inspired by the proof of
Theorem 2.4 of Lynch et al. (2014).
Proof of Theorem 5.3: We note that for i = 1, . . . ,m, if there are i rejections, then
i ≤ Ji ≤ m. For i, j = 1, . . . ,m, define,
fi(j) =

m−j
m−iα
Si
i
, if i < m,
0, if i = m
(5.15)
and Wi(j) = I{Ji−1 ≤ j, Ji > j}. We use the following two inequalities, proved in
Lynch et al. (2014),
I{Ji = j} = Wi(j − 1)I{Pj ≤ αj} (5.16)
and
Wi(j)−Wi(j − 1) = I{Ji−1 = j} − I{Ji = j}. (5.17)
Here, αj’s are those defined in Procedure 5.3. We next use the following two more
equations, the proofs of which are given in Appendix B,
E
((
Vi
i
− Vi−1
i− 1 + fi(j)− fi−1(j)
)
I{Ji = j}
)
≤ E
(
α
m− i+ 1
Si−1
i− 1Wi(j − 1)
)
(5.18)
and
E (fi−1(Ji−1)I{Ji−1 < m+ 1} − fi−1(Ji)I{Ji < m+ 1})
= E
(
m∑
j=i
α
m− i+ 1
Si−1
i− 1Wi(j − 1)
)
. (5.19)
Next, from Lemma 5.1, we get the desired result as follows:
FDR =
m∑
i=1
E
((
Vi
i
− Vi−1
i− 1
)
I{Ji < m+ 1}
)
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=
m∑
i=1
E
(
m∑
j=i
(
Vi
i
− Vi−1
i− 1 + fi(j)− fi−1(j)
)
I{Ji = j}
)
−
m∑
i=1
E (fi−1(Ji−1)I{Ji−1 < m+ 1} − fi−1(Ji)I{Ji < m+ 1})
+
m∑
i=1
E (fi−1(Ji−1)I{Ji−1 < m+ 1} − fi(Ji)I{Ji < m+ 1})
≤
m∑
i=1
E (fi−1(Ji−1)I{Ji−1 < m+ 1} − fi(Ji)I{Ji < m+ 1}) (5.20)
= E
(
m− J0
m
α I{J0 < m+ 1} − 0
)
≤ α. (5.21)
The inequality in (5.20) follows by (5.18) and (5.19). 
Remark 5.5. The critical constants in Procedure 5.3 are much larger than the critical
constants in Procedure 5.1. As a result, intuitively, Procedure 5.3 is much more
powerful than Procedure 5.1.
5.5 Simulation Study
We did a simulation study to compare the performance of the proposed Procedures
5.1 - 5.3 in terms of FDR control and average power for different combinations of true
and false null hypotheses. According to our knowledge, the only procedures available
in the literature that are able to handle the testing in the applications discussed
here are the Bonferroni procedure, Fallback procedure (Wiens, 2003) and Qiu et al.
(2014)’s Generalized Fixed Sequence Procedures. These procedures are developed in
the framework of FWER control so they can conservatively control FDR. We compare
the performance of the proposed procedures, Procedure 5.1 (PRDS), Procedure
5.2 (Arbitrary Dependence), Procedure 5.3 (Independence) to the Wiens (2003)’s
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Fallback procedure and Qiu et al. (2014)’s Generalized Fixed Sequence Procedure
A1.
5.5.1 Study Design
The hypotheses we want to test, for i = 1, . . . ,m, are as follows:
H0i : µ = µ0
vs. (5.22)
H1i : µ = µ1,
where, µ0 denotes the “in control” mean and µ1 denotes the “out of control” mean.
We simulate test statistics T1, . . . , Tm from normal distribution, where, m denotes
the number of hypotheses tested in a sequence. The true null test statistics, m0 in
number, are from N(µ0, σ
2) distribution. The false null test statistics, m1 = m−m0 in
number, are from N(µ1, σ
2) distribution. The test statistics are taken to be correlated
with the following variance-covariance matrix which we call Adjacent-Correlation, as
only the adjacent test statistics are correlated,
ΣAdjacentm×m =

σ2 ρσ2 0 · · · 0 0
ρσ2 σ2 ρσ2 · · · 0 0
...
...
...
. . .
...
...
0 0 0 · · · σ2 ρσ2
0 0 0 · · · ρσ2 σ2

. (5.23)
For the simulation, we generate µ0 from Uniform distribution on interval [0, 3]
and µ1 from Uniform distribution on interval [3, 6]. We fix σ
2 = 1. We consider
the values ρ = 0, 0.2, 0.5, 0.8, to account for different degrees of correlation from
independence to strong correlation while testing m = 200, 400 hypotheses. The
weights used in the proposed Fallback-type FDR controlling procedures and the
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Fallback procedure (Wiens, 2003) are equal weights. The p-values are calculated
as,
Pi = Prµ=µ0 (Ti ≥ ti) ,
where, ti denote the observed values of Ti, i = 1, . . . ,m.
Order of Hypotheses: We consider a pre-specified order of the hypotheses
which conforms to the special structure of hypotheses discussed in Section 5.3.
For choosing each null hypothesis, we generate a random number from Bernoulli
distribution with outcomes “false” and “true”. The outcome “false” has probability
pi. Thus, a null hypothesis is set to be false with probability pi and set to be true
with probability (1 − pi). Here, pi is generally fixed low, say, 0.1, as we expect that
the procedure is “in control” most of the time.
5.5.2 Results of The Simulation Study
Independence: We summarize the results of the simulation studies for the
independence case in Figure 5.2. The vertical axis denotes the average FDR (left
panel) and average power (right panel) for different values of pi along the horizontal
axis for m = 200 and 400. As desired, all five procedures control the FDR on average
at α = 0.05. However, the proposed procedure under independence, Procedure 5.3,
has the highest power compared to all other methods.
Dependence: We summarize the results of the simulation studies for the dependence
case in Figures 5.3-5.5. The correlation we consider is Adjacent-Correlation as in
(5.23) with ρ = 0.2, 0.5, 0.8. Again, as desired, all four procedures control the FDR
on average at α = 0.05. However, the proposed procedure under PRDS, Procedure
5.1, has the highest power compared to all other methods.
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Figure 5.2 FDR and Average Power for m = 200, 400 hypotheses under
independence (ρ = 0).
5.6 Summary and Conclusion
In this chapter, we develop multiple testing procedures that control the FDR and are
appropriate for testing a-priori ordered hypotheses in the applications such as network
monitoring in stream data, Statistical Process Control, etc., where we need to make
real-time decisions based on the partial information available at the time of testing.
We developed procedures that cover different dependence scenarios. Our simulation
study shows that our proposed procedures always outperform the Fallback procedure
(Wiens, 2003) and the Qiu et al. (2014)’s Generalized Fixed Sequence Procedure A1.
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Figure 5.3 FDR and Average Power for m = 200, 400 hypotheses under Adjacent-
Correlation with ρ = 0.2.
But this is expected as both these procedures are developed to control FWER and
perform conservatively in FDR framework.
In the simulation study, we considered the correlation structure where only the
adjacent test statistics and as a result, only the adjacent p-values are correlated. It
would be interesting to see how the procedures perform in other kinds of correlation
structures, a few examples would be equal correlation structure, AR(1) correlation
structure, etc.
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Figure 5.4 FDR and Average Power for m = 200, 400 hypotheses under Adjacent-
Correlation with ρ = 0.5.
The procedures developed in this chapter are for the scenario where, m, the
number of hypotheses tested in a sequence is finite. As a future work, it will be
interesting to develop procedures that can handle the case when m is not finite.
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Figure 5.5 FDR and Average Power for m = 200, 400 hypotheses under Adjacent-
Correlation with ρ = 0.8.
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CHAPTER 6
CONCLUSION AND FUTURE WORK
In this dissertation, we consider testing hypotheses with several different types
of structures that sometimes require making directional decisions based on the
problem of interest, and develop novel methods which exploit these inherent complex
structures.
In Chapter 2, we present a general procedure for large scale multiple testing
of hierarchically structured families of hypotheses while making multidimensional
directional decisions with proven control of mdFDR. The approach developed in this
chapter can also be used for addressing the problem of variable selection in high-
dimensional regression, where data is available on thousands of features/explanatory
variables. In large scale data, where the response of different study groups is available
for the explanatory variables, the variable selection problem for modeling the response
from the different study groups can be formulated as a multiple testing problem with
families of hypotheses having similar hierarchical structure discussed in this research.
The idea is inspired by the hierarchical approach proposed in Meinshausen (2008),
where, variable importance is first tested at the coarsest level, corresponding to the
global null hypothesis and the method then tries to attribute any effect to smaller
subclusters or even individual variables while controlling FWER. A future direction of
research related to the work in Chapter 2 is to explore methods for variable selection
for each study groups in the data while controlling FDR.
In Chapter 3, we develop a specific methodology based on the general procedure
presented in Chapter 2 and use it for Uterine Fibroid gene expression data analysis to
identify important genes and pathways associated with formation and growth of the
fibroids. The results we obtained are confounded by the race and age groups of the
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subjects in the study. A future direction of research related to this work is to explore
methods for testing that remove this confounding effect and gain deeper insights into
genes and pathways associated with fibroids.
In Chapter 4, we consider the problem of simultaneously testing multiple
pre-ordered hypotheses accompanied by directional decisions. The conventional
fixed sequence procedure augmented with additional directional decisions is proved
to control the mdFWER under independence and some dependence. A more
conservative procedure is developed under arbitrary dependence of test statistics. A
future direction of research related to the work in Chapter 4 is to explore the challenge
of attacking the notoriously challenging problem of controlling the mdFWER for
p-value ordered stepwise procedures. Another direction for future research is to
explore the development of fixed sequence type multiple testing methods for group
sequential designs in clinical trials where the hypotheses tested at different stages act
a gatekeepers for future hypotheses.
Finally in Chapter 5, we present several new FDR controlling procedures for
large scale testing of a-priori ordered hypotheses in applications such as stream data,
statistical process control, etc. We developed the procedures for testing a sequence of
hypotheses where the total number of hypotheses tested in the sequence is fixed. A
future direction of research related to the work in Chapter 5 is to explore the problem
of testing multiple pre-ordered families of hypotheses. Another direction for future
research is to develop generalized fixed sequence procedures for controlling the FDR.
As a concluding remark, we would like to point out that we developed methods
in this dissertation that have varied applications in different fields and provide a
good direction for the research in development of new and powerful multiple testing
procedures.
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APPENDIX A
This appendix contains the proofs of the lemmas and theorems stated but not proved
in Chapter 4.
A.1 Proof of Lemma 4.1.
Let T and P denote the test statistic and the corresponding p-value for testing H,
respectively. When testing H, a Type III error occurs if H is rejected and θT < 0.
Then, the Type III error rate is given by Pr(P ≤ α, θT < 0).
When θ > 0, we have
Pr(P ≤ α, θT < 0) = Pr(2F0(T ) ≤ α, T < 0)
= Pr
(
T ≤ F−10
(α
2
))
= Fθ
(
F−10
(α
2
))
≤ F0
(
F−10
(α
2
))
=
α
2
.
The inequality follows from the assumption that Fθ is stochastically increasing in θ.
Similarly, when θ < 0, we can also prove that Pr(P ≤ α, θT < 0) ≤ α
2
. 
A.2 Proof of Theorem 4.1
(i). Induction will be used to show that Procedure 1 strongly controls the mdFWER
at level α. First, consider the case of n = 2. We show control of the mdFWER
of Procedure 4.1 in all possible combinations of true and false null hypotheses while
testing two hypotheses H1 and H2.
Case I: H1 is true. Type I or Type III error occurs only when H1 is rejected.
mdFWER = Pr(P1 ≤ α) ≤ α.
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Case II: Both H1 and H2 are false. We have no Type I errors but only Type III
errors.
mdFWER = Pr({P1 ≤ α, T1θ1 < 0} ∪ {P1 ≤ α, P2 ≤ α, T2θ2 < 0})
≤ Pr(P1 ≤ α, T1θ1 < 0) + Pr(P2 ≤ α, T2θ2 < 0)
≤ α
2
+
α
2
= α.
The first inequality follows from Bonferroni inequality and the second follows from
Lemma 4.1.
Case III: H1 is false and H2 is true. The mdFWER is bounded above by
Pr( make Type III error when testing H1)
+Pr( make Type I error when testing H2)
≤ Pr(P1 ≤ α, T1θ1 < 0) + Pr(P2 ≤ α/2)
≤ α
2
+
α
2
= α.
The first inequality follows from Bonferroni inequality and the second follows from
Lemma 4.1 and P2 ∼ U(0, 1) since H2 is true.
Now assume the inductive hypothesis that the mdFWER is bounded above by
α when testing at most n − 1 hypotheses by using Procedure 4.1 at level α. In
the following, we prove the mdFWER is also bounded above by α when testing n
hypotheses H1, . . . , Hn. Without loss of generality, assume H1 is a false null (if H1 is
a true null, the desired result directly follows by using the same argument as in Case
I of n = 2). Then, the mdFWER is bounded above by
Pr( make Type III error when testing H1)
+ Pr( make at least one Type I or Type III errors when testing H2, . . . , Hn)
≤ α
2
+
α
2
= α.
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The inequality follows from the induction assumption, noticing that H2, . . . , Hn are
tested by using Procedure 4.1 at level α/2. Thus, the desired result follows.
(ii). We now prove that the critical constants are unimprovable. For instance, when
H1 is true, it is easy to see that the first critical constant, α, is unimprovable. For each
given k = 2, . . . , n, when θi > 0, i = 1, . . . , k−1 and θk = 0, that is, Hi, i = 1, . . . , k−1
are false and Hk is true, we present a simple joint distribution of the test statistics
T1, . . . , Tk to show that the kth critical constant of this procedure is also unimprovable.
Define Zk ∼ N(0, 1) and Zi = Φ−1(|2Φ(Zi+1)− 1|), i = 1, . . . , k − 1, where Φ(·)
is the cdf of N(0, 1). Let qi denote Zi’s upper α/2
i quantile. It is easy to check that
for each i = 1, . . . , k, Zi ∼ N(0, 1). Thus, −qi is Zi’s lower α/2i quantile. In addition,
by the construction of Zi’s, it is easy to see that the event Zi ≥ qi is equivalent to
the event Zi+1 /∈ (−qi+1, qi+1).
Let Ti = Zi + θi, i = 1, . . . , k, thus, Ti ∼ N(θi, 1). Then, as θi → 0+ for
i = 1, . . . , k − 1, we have
mdFWER =
k−1∑
j=1
Pr(T1 ≥ q1, . . . , Tj−1 ≥ qj−1, Tj ≤ −qj)
+ Pr(T1 ≥ q1, . . . , Tk−1 ≥ qk−1, Tk /∈ (−qk, qk))
=
k−1∑
j=1
Pr(Z1 ≥ q1, . . . , Zj−1 ≥ qj−1, Zj ≤ −qj)
+ Pr(Z1 ≥ q1, . . . , Zk−1 ≥ qk−1, Zk /∈ (−qk, qk))
=
k−1∑
j=1
Pr(Zj ≤ −qj) + Pr(Zk /∈ (−qk, qk))
=
k−1∑
j=1
α
2j
+
α
2(k−1)
= α.
Thus, the kth critical constant of Procedure 4.1 is unimprovable and hence each
critical constant of Procedure 4.1 is unimprovable under arbitrary dependence. 
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A.3 Proof of Lemma 4.2.
Note that when θ1 > 0 and θ2 = 0, we have
mdFWER
= Pr (P1 ≤ α, θ1T1 < 0) + Pr (P1 ≤ α, θ1T1 ≥ 0, P2 ≤ α)
= Pr (P1 ≤ α, T1 < 0) + Pr (P1 ≤ α, T1 ≥ 0, P2 ≤ α, T2 > 0)
+Pr (P1 ≤ α, T1 ≥ 0, P2 ≤ α, T2 ≤ 0)
= Pr (2F0(T1) ≤ α) + Pr (2(1− F0(T1)) ≤ α, 2(1− F0(T2)) ≤ α)
+Pr (2(1− F0(T1)) ≤ α, 2F0(T2) ≤ α)
= Pr (T1 ≤ c1) + Pr (T1 ≥ c2, T2 ≥ c2) + Pr (T1 ≥ c2, T2 ≤ c1)
= Fθ1(c1) + 1− Fθ1(c2)− F0(c2) + F(θ1,0)(c2, c2) + F0(c1)− F(θ1,0)(c2, c1)
= α + Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c2, c2)− F(θ1,0)(c2, c1). (A.1)
Specifically, under Assumption 4.1 (independence), (A.1) can be simplified as,
α + Fθ1(c1)− Fθ1(c2) + Fθ1(c2)F0(c2)− Fθ1(c2)F0(c1)
= α + Fθ1(c1)− αFθ1(c2).
Similarly, when θ1 < 0 and θ2 = 0, we can prove that
mdFWER = 1 + Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c1, c1)− F(θ1,0)(c1, c2).

A.4 Proof of Lemma 4.3
By using the same arguments as in Theorem 4.1, we can easily prove control of the
mdFWER of Procedure 4.2 in the case of n = 2 when H1 is true or both H1 and H2
are false. In the following, we prove the desired result also holds when H1 is false and
H2 is true.
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Note that H1 is false and H2 is true imply θ1 6= 0 and θ2 = 0. To show that the
mdFWER is controlled for θ1 > 0 and θ2 = 0, we only need to show by Lemma 4.2
that α + Fθ1(c1)− αFθ1(c2) ≤ α. This is equivalent to show
Fθ1(c2) (F0(c2)− F0(c1)) ≤ Fθ1(c2)− Fθ1(c1). (A.2)
For proving (A.2), it is enough to prove the following, as 0 ≤ F0(c2) ≤ 1,
Fθ1(c2) (F0(c2)− F0(c1)) ≤ F0(c2) (Fθ1(c2)− Fθ1(c1)) . (A.3)
Dividing both sides of (A.3) by Fθ1(c2)F0(c2), we see that we only need to prove,
1− F0(c1)
F0(c2)
≤ 1− Fθ1(c1)
Fθ1(c2)
,
which follows directly from (4.5) and Assumption 4.2 (MLR).
Similarly, to show that the mdFWER is controlled for θ1 < 0 and θ2 = 0, we
only need to show by Lemma 4.2 that 1 + αFθ1(c1)− Fθ1(c2) ≤ α. This is equivalent
to showing
(1− α) (1− Fθ1(c1)) ≤ Fθ1(c2)− Fθ1(c1).
Writing 1 − α as (1− F0(c1)) − (1− F0(c2)) and writing Fθ1(c2) − Fθ1(c1) as
(1− Fθ1(c1))− (1− Fθ1(c2)), we get that it is equivalent to prove
[(1− F0(c1))− (1− F0(c2))] (1− Fθ1(c1)) ≤ (1− Fθ1(c1))− (1− Fθ1(c2)) . (A.4)
Since 0 ≤ 1−F0(c1) ≤ 1, to prove inequality (A.4), it is enough to prove the following,
(1− Fθ1(c1)) [(1− F0(c1))− (1− F0(c2))]
≤ (1− F0(c1)) [1− Fθ1(c1)]− [1− Fθ1(c2)] . (A.5)
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Dividing both sides of (A.5) by (1− Fθ1(c1)) (1− F0(c1)), we see that proving (A.4)
is equivalent to showing
1− Fθ1(c2)
1− Fθ1(c1)
≤ 1− F0(c2)
1− F0(c1) , (A.6)
which follows directly from (4.6) and Assumption 4.2 (MLR).
By combining the discussion of the above two cases, the desired result follows. 
A.5 Proof of Theorem 4.2
The proof is by induction on number of hypotheses n. We already proved strong
control of the mdFWER for n = 2 in Lemma 4.3. Let us assume the result holds for
testing any n = k hypotheses, that is, mdFWER ≤ α while testing any k pre-ordered
hypotheses. We now argue that is will hold for n = k + 1 hypotheses. Without loss
of generality, assume H1 is a false null, as in the proof of Theorem 4.1.
Let V
(−1)
k+1 denote the total number of Type I or Type III errors committed
while testing H2, . . . , Hk+1 and excluding H1. Then, by the inductive hypothesis, the
mdFWER while testing the k hypotheses H2, . . . , Hk+1 is Pr(V
(−1)
k+1 > 0) ≤ α. Then,
the mdFWER of testing k + 1 hypotheses H1, . . . , Hk+1 is defined by
Pr
(
{P1 ≤ α, T1θ1 < 0} ∪ {P1 ≤ α, T1θ1 ≥ 0, V (−1)k+1 > 0}
)
= Pr (P1 ≤ α, T1θ1 < 0) + Pr (P1 ≤ α, T1θ1 ≥ 0) · Pr
(
V
(−1)
k+1 > 0
)
≤ Pr (P1 ≤ α, T1θ1 < 0) + α Pr (P1 ≤ α, T1θ1 ≥ 0) . (A.7)
The equality follows by Assumption 4.1 (independence) and the inequality follows by
the inductive hypothesis. Note that (A.7) is the same as (4.8) under independence,
which is equal to the mdFWER of Procedure 4.2 in the case of two hypotheses. So
again by applying Lemma 4.3, we get that mdFWER ≤ α for n = k + 1. Hence, the
proof follows by induction. 
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A.6 Proof of Theorem 4.3
Without loss of generality, we assume θi > 0 if θi 6= 0 for i = 1, . . . , n. Also, if there
exists an i with θi = 0, by induction, we can simply assume i0 = n. Thus, to prove
the mdFWER control of Procedure 4.2, we only need to consider two cases:
(i) θi > 0 for i = 1, . . . , n;
(ii) θi > 0 for i = 1, . . . , n− 1 and θn = 0.
Case (i). Consider the general case of θi > 0, i = 1, . . . , n. By Assumption 4.3, the
test statistics T1, . . . , Tn are positively regression dependent. For j = 1, . . . , n− 1, let
En−j denote the event of making at least one Type III error when testing Hj+1, . . . , Hn
using Procedure 4.2 at level α. By using induction, we prove the following two lemmas
hold.
Lemma A.1. Assume the conditions of Theorem 4.3. For j = 1, . . . , n − 1, the
following inequality holds.
Pr(En−j|T1 > c2, . . . , Tj > c2) ≤ α. (A.8)
Proof of Lemma A.1. We prove the result by using reverse induction. When
j = n− 1, we have
Pr(En−j|T1 > c2, . . . , Tj > c2)
= Pr(Tn < c1|T1 > c2, . . . , Tn−1 > c2)
=
Pr(Tn < c1)Pr(T1 > c2, . . . , Tn−1 > c2|Tn < c1)
Pr(T1 > c2, . . . , Tn−1 > c2)
≤ Pr(Tn < c1) ≤ α.
The inequality follows from Assumption 4.3.
Assume the inequality (A.8) holds for j = m. In the following, we prove that it
also holds for j = m− 1. Note that
Pr(En−m+1|T1 > c2, . . . , Tm−1 > c2)
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= Pr
(
{Tm < c1}
⋃(
{Tm > c2}
⋂
En−m
) ∣∣T1 > c2, . . . , Tm−1 > c2)
= Pr
(
Tm < c1
∣∣T1 > c2, . . . , Tm−1 > c2)+ Pr ({Tm > c2}⋂En−m∣∣T1 > c2, . . . , Tm−1 > c2)
= Pr
(
Tm < c1
∣∣T1 > c2, . . . , Tm−1 > c2)
+ Pr
(
Tm > c2
∣∣T1 > c2, . . . , Tm−1 > c2)Pr (En−m∣∣T1 > c2, . . . , Tm > c2)
≤ Pr (Tm < c1∣∣T1 > c2, . . . , Tm−1 > c2)+ αPr (Tm > c2∣∣T1 > c2, . . . , Tm−1 > c2)
≤ α.
Therefore, the desired result follows. Here, the first inequality follows from the
assumption of induction and the second follows from Lemma A.2 below. 
Lemma A.2. Assume the conditions of Theorem 4.3. For j = 1, . . . , n − 1, the
following inequality holds:
Pr
(
Tj < c1
∣∣T1 > c2, . . . , Tj−1 > c2)+ αPr (Tj > c2∣∣T1 > c2, . . . , Tj−1 > c2) ≤ α.
(A.9)
Specifically, for j = 1, we have
Pr (T1 < c1) + αPr (T1 > c2) ≤ α.
Proof of Lemma A.2. To prove the inequality (A.9), it is enough to show that
Pr
(
Tj < c1
∣∣T1 > c2, . . . , Tj−1 > c2) ≤ αPr (Tj < c2∣∣T1 > c2, . . . , Tj−1 > c2) ,
which is equivalent to
(1− α)Pr (Tj < c2∣∣T1 > c2, . . . , Tj−1 > c2)
≤ Pr (Tj < c2∣∣T1 > c2, . . . , Tj−1 > c2)− Pr (Tj < c1∣∣T1 > c2, . . . , Tj−1 > c2) .
Note that
1− α = Prθj=0(Tj < c2)− Prθj=0(Tj < c1).
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Thus, the above inequality is equivalent to
Prθj=0(Tj < c2)− Prθj=0(Tj < c1) ≤ 1−
Pr
(
Tj < c1
∣∣T1 > c2, . . . , Tj−1 > c2)
Pr
(
Tj < c2
∣∣T1 > c2, . . . , Tj−1 > c2) ,
which in turn is implied by
1− Prθj=0(Tj < c1)
Prθj=0(Tj < c2)
≤ 1− Pr
(
Tj < c1
∣∣T1 > c2, . . . , Tj−1 > c2)
Pr
(
Tj < c2
∣∣T1 > c2, . . . , Tj−1 > c2) . (A.10)
Note that by Assumption 4.2, we have
Pr(Tj < c1)
Pr(Tj < c2)
≤ Prθj=0(Tj < c1)
Prθj=0(Tj < c2)
.
Thus, to prove the inequality (A.10), we only need to show that
Pr
(
Tj < c1
∣∣T1 > c2, . . . , Tj−1 > c2)
Pr
(
Tj < c2
∣∣T1 > c2, . . . , Tj−1 > c2) ≤ Pr(Tj < c1)Pr(Tj < c2) ,
which is equivalent to
Pr
(
T1 > c2, . . . , Tj−1 > c2
∣∣Tj < c1) ≤ Pr (T1 > c2, . . . , Tj−1 > c2∣∣Tj < c2) ,
which follows from Assumption 4.3. Therefore, the desired result follows. 
Based on Lemmas A.1 and A.2, we have
mdFWER = Pr(T1 < c1) +
n∑
j=2
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1)
= Pr(T1 < c1) + Pr(T1 > c2)
n∑
j=2
Pr(T2 > c2, . . . , Tj−1 > c2, Tj < c1|T1 > c2)
= Pr(T1 < c1) + Pr(T1 > c2)Pr(En−1|T1 > c2)
≤ Pr(T1 < c1) + αPr(T1 > c2)
≤ α.
Therefore, the mdFWER is controlled at level α for Case (i). Here, the first inequality
follows from Lemma A.1 and the second follows from Lemma A.2.
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Case (ii). Consider the general case of θi > 0, i = 1, . . . , n − 1 and θn = 0. Under
Assumption 4.3, Ti, i = 1, . . . , n − 1 are positively regression dependent and under
Assumption 4.4, Tn is independent of Ti’s . Note that
mdFWER
=
n−1∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1)
+ Pr(T1 > c2, . . . , Tn−1 > c2, Tn < c1) + Pr(T1 > c2, . . . , Tn > c2)
=
n−1∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1) + αPr(T1 > c2, . . . , Tn−1 > c2).
The second equality follows from Assumption 4.4.
For m = 1, . . . , n− 1, define
∆m =
m∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1) + αPr(T1 > c2, . . . , Tm > c2).
Thus, mdFWER = ∆n−1. By using induction, we prove below that ∆m ≤ α for
m = 1, . . . , n− 1.
For m = 1, by using Lemma A.2, we have
∆1 = Pr (T1 < c1) + αPr (T1 > c2) ≤ α.
Assume ∆m ≤ α. In the following, we show ∆m+1 ≤ α. Note that
∆m+1 =
m+1∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1)
+ αPr(T1 > c2, . . . , Tm > c2, Tm+1 > c2)
=
m∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1)
+ Pr(T1 > c2, . . . , Tm > c2) [Pr(Tm+1 < c1|T1 > c2, . . . , Tm > c2)
+ αPr(Tm+1 > c2|T1 > c2, . . . , Tm > c2)]
≤
m∑
j=1
Pr(T1 > c2, . . . , Tj−1 > c2, Tj < c1) + αPr(T1 > c2, . . . , Tm > c2)
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= ∆m ≤ α. (A.11)
The first inequality follows from Lemma A.2 and the second follows from the inductive
hypothesis. Thus, ∆m ≤ α for m = 1, . . . , n− 1. Therefore, mdFWER = ∆n−1 ≤ α,
the desired result.
Combining the arguments of Cases (i) and (ii), the proof of Theorem 4.3 is
complete. 
A.7 Proof of Proposition 4.1
From the proof of Theorem 4.1 and by Lemma 4.1, it is easy to see that we only need
to prove the mdFWER control of Procedure 4.2 when H1 is false and H2 is true, i.e.,
θ1 6= 0 and θ2 = 0.
Case I: θ1 > 0 and θ2 = 0. By Lemma 4.2, the mdFWER of Procedure 4.2 is
controlled at level α if we have the following:
Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c2, c2)− F(θ1,0)(c2, c1) ≤ 0.
After rewriting F(θ1,0)(x, y) as Pr(T1 ≤ x, T2 ≤ y) and then dividing through by
Pr(T1 ≤ c2), we get,
Pr (T2 ≤ c2|T1 ≤ c2)− Pr (T2 ≤ c1|T1 ≤ c2) ≤ 1− Pr(T1 ≤ c1)
Pr(T1 ≤ c2) .
Dividing by Pr (T2 ≤ c2|T1 ≤ c2), we get,
1− Pr (T2 ≤ c1|T1 ≤ c2)
Pr (T2 ≤ c2|T1 ≤ c2) ≤
1
Pr (T2 ≤ c2|T1 ≤ c2)
(
1− Pr(T1 ≤ c1)
Pr(T1 ≤ c2)
)
. (A.12)
For proving (A.12), it is enough to prove the following inequality, as 1
Pr(T2≤c2|T1≤c2) ≥
1.
1− Pr (T2 ≤ c1|T1 ≤ c2)
Pr (T2 ≤ c2|T1 ≤ c2) ≤ 1−
Pr(T1 ≤ c1)
Pr(T1 ≤ c2) . (A.13)
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By Assumption 4.2 and (4.5), it follows that F0(c2)
F0(c1)
≤ Fθ1 (c2)
Fθ1 (c1)
, which is equivalent to,
1 − Pr(T2≤c1)
Pr(T2≤c2) ≤ 1 −
Pr(T1≤c1)
Pr(T1≤c2) . Thus, for proving (A.12), it is enough to prove the
following:
1− Pr (T2 ≤ c1|T1 ≤ c2)
Pr (T2 ≤ c2|T1 ≤ c2) ≤ 1−
Pr(T2 ≤ c1)
Pr(T2 ≤ c2) . (A.14)
But, (A.14) is equivalent to showing
Pr (T1 ≤ c2|T2 ≤ c1) ≥ Pr (T1 ≤ c2|T2 ≤ c2) ,
which follows directly from Assumption 4.5.
Case II: θ1 < 0 and θ2 = 0. Similarly, by Lemma 4.2, the mdFWER of Procedure
4.2 is controlled at level α if we have the following:
1 + Fθ1(c1)− Fθ1(c2) + F(θ1,0)(c1, c1)− F(θ1,0)(c1, c2) ≤ α, (A.15)
which after some rearrangement and rewriting 1− α as F0(c2)− F0(c1) gives,
(
F0(c2)− F(θ1,0)(c1, c2)
)− (F0(c1)− F(θ1,0)(c1, c1)) ≤ (1− Fθ1(c1))− (1− Fθ1(c2)) .
(A.16)
Thus, proving (A.15) is equivalent to proving that
Pr (T1 ≥ c1, T2 ≤ c2)− Pr (T1 ≥ c1, T2 ≤ c1) ≤ Pr (T1 ≥ c1)− Pr (T1 ≥ c2) .
Dividing through by Pr(T1 ≥ c1), we get
Pr (T2 ≥ c1|T1 ≥ c1)− Pr (T2 ≥ c2|T1 ≥ c1) ≤ 1− Pr(T1 ≥ c2)
Pr(T1 ≥ c1) . (A.17)
Thus, to prove (A.15), it is enough to prove the following,
1− Pr (T2 ≥ c2|T1 ≥ c1)
Pr (T2 ≥ c1|T1 ≥ c1) ≤ 1−
Pr(T1 ≥ c2)
Pr(T1 ≥ c1) ,
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which is equivalent to proving,
Pr (T2 ≥ c2|T1 ≥ c1)
Pr (T2 ≥ c1|T1 ≥ c1) ≥
Pr(T1 ≥ c2)
Pr(T1 ≥ c1) . (A.18)
By Assumption 4.2 and (4.6), it follows that for θ1 < 0,
Pr(T1≥c2)
Pr(T1≥c1) ≤
Pr(T2≥c2)
Pr(T2≥c1) . Thus,
to prove (A.15), it is enough to prove the following,
Pr (T2 ≥ c2|T1 ≥ c1)
Pr (T2 ≥ c1|T1 ≥ c1) ≥
Pr(T2 ≥ c2)
Pr(T2 ≥ c1) . (A.19)
But (A.19) is equivalent to showing
Pr (T1 ≥ c1|T2 ≥ c2) ≥ Pr (T1 ≥ c1|T2 ≥ c1) , (A.20)
which follows directly from Assumption 4.5. By combining the arguments of the
above two cases, the desired result follows. 
A.8 Proof of Proposition 4.2
By Corollary 4.1, without loss of generality, assume that θi > 0, i = 1, 2 and θ3 = 0,
that is, H1 and H2 are false and H3 is true. Note that
mdFWER
= Pr(T1 ≤ c1) + Pr(T1 ≥ c2, T2 ≤ c1) + Pr (T1 ≥ c2, T2 ≥ c2, T3 /∈ (c1, c2)) . (A.21)
In the following, we prove that
Pr(T1 ≥ c2, T2 ≤ c1) + Pr (T1 ≥ c2, T2 ≥ c2, T3 /∈ (c1, c2))
≤ Pr (T1 ≥ c2, T3 /∈ (c1, c2)) . (A.22)
To prove (A.22), it is enough to show the following inequality:
Pr(T2 ≤ c1|T1) + Pr (T2 ≥ c2, T3 /∈ (c1, c2)|T1) ≤ Pr (T3 /∈ (c1, c2)|T1) . (A.23)
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Note that
Pr (T2 ≥ c2, T3 ≤ c1|T1) = Pr(T3 ≤ c1|T1)− Pr (T2 < c2, T3 ≤ c1|T1) (A.24)
and
Pr (T2 ≥ c2, T3 ≥ c2|T1)
= 1− Pr(T2 < c2|T1)− Pr(T3 < c2|T1) + Pr (T2 < c2, T3 < c2|T1) . (A.25)
In addition, we have
Pr (T3 /∈ (c1, c2)|T1) = 1 + Pr(T3 ≤ c1|T1)− Pr(T3 < c2|T1). (A.26)
Thus, in order to show (A.23), by combining (A.24)-(A.26), we only need to prove
the following inequality:
Pr (T2 < c2, T3 < c2|T1)− Pr (T2 < c2, T3 ≤ c1|T1)
≤ Pr(T2 < c2|T1)− Pr(T2 ≤ c1|T1). (A.27)
Note that (A.27) can be rewritten as
Pr (T2 < c2, T3 < c2|T1)
[
1− Pr (T2 < c2, T3 ≤ c1|T1)
Pr (T2 < c2, T3 < c2|T1)
]
≤ Pr(T2 < c2|T1)
[
1− Pr(T2 ≤ c1|T1)
Pr(T2 < c2|T1)
]
. (A.28)
Thus, to prove (A.27), it is enough to show
1− Pr (T2 < c2, T3 ≤ c1|T1)
Pr (T2 < c2, T3 < c2|T1) ≤ 1−
Pr(T2 ≤ c1|T1)
Pr(T2 < c2|T1) . (A.29)
That is,
Pr(T2 ≤ c1|T1)
Pr(T2 < c2|T1) ≤
Pr (T2 < c2, T3 ≤ c1|T1)
Pr (T2 < c2, T3 < c2|T1) . (A.30)
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By Assumption 4.6 (BMLR), we have
Pr(T2 ≤ x2|T1)
Pr(T3 ≤ x2|T1) ≥
Pr(T2 ≤ x1|T1)
Pr(T3 ≤ x1|T1) . (A.31)
By (A.31), to prove (A.30), it is enough to show
Pr(T3 ≤ c1|T1)
Pr(T3 < c2|T1) ≤
Pr (T2 < c2, T3 ≤ c1|T1)
Pr (T2 < c2, T3 < c2|T1) . (A.32)
That is,
Pr (T2 < c2|T3 < c2, T1) ≤ Pr (T2 < c2|T3 < c1, T1) . (A.33)
The inequality (A.33) holds under Assumption 4.5. Therefore, the inequality (A.22)
holds.
Based on (A.21)-(A.22) and Proposition 1, we have
mdFWER = Pr(T1 ≤ c1) + Pr (T1 ≥ c2, T3 /∈ (c1, c2)) ≤ α.
Thus, the desired result follows. 
A.9 Proof of Theorem 4.4
By Corollary 4.1, without loss of generality, assume that θi > 0, i = 1, . . . , n− 1 and
θn = 0, that is, Hi, i = 1, . . . , n− 1 are false and Hn is true. Note that
mdFWER (A.34)
=
n−1∑
j=1
Pr(T1 ≥ c2, . . . , Tj−1 ≥ c2, Tj ≤ c1) + Pr(T1 ≥ c2, . . . , Tn−1 ≥ c2, Tn /∈ (c1, c2)).
In the following, we prove that
Pr(T1 ≥ c2, . . . , Tn−2 ≥ c2, Tn−1 ≤ c1) + Pr (T1 ≥ c2, . . . , Tn−1 ≥ c2, Tn /∈ (c1, c2))
≤ Pr (T1 ≥ c2, . . . , Tn−2 ≥ c2, Tn /∈ (c1, c2)) . (A.35)
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To prove (A.35), it is enough to show the following inequality:
Pr(Tn−1 ≤ c1|T1, . . . , Tn−2) + Pr (Tn−1 ≥ c2, Tn /∈ (c1, c2)|T1, . . . , Tn−2)
≤ Pr (Tn /∈ (c1, c2)|T1, . . . , Tn−2) . (A.36)
By using the same argument as in proving (A.23) in the case of three hypotheses, we
can prove that the inequality (A.36) holds under Assumptions 4.5 and 4.7. Then, by
combining (A.34) and (A.35), we have
mdFWER (A.37)
≤
n−2∑
j=1
Pr(T1 ≥ c2, . . . , Tj−1 ≥ c2, Tj ≤ c1) + Pr(T1 ≥ c2, . . . , Tn−2 ≥ c2, Tn /∈ (c1, c2)).
Note that the right-hand side of (A.37) is the mdFWER of Procedure 4.2 when testing
H1, . . . , Hn−2, Hn. By induction and Proposition 1, the mdFWER is bounded above
by α, the desired result.
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APPENDIX B
This appendix contains the proofs of the lemmas and theorems stated but not proved
in Chapter 5.
B.1 Proof of Theorem 5.2
Proof As noted in the proof of Theorem 5.1, we have,
FDR =
m0∑
i=1
E
(
V
V + S
I {U = ui}
)
(B.1)
For each ui, let us define,
βr =
(
m− ui + 1 + r
m− ui + 1
)
· αui
cui
, r = 0, . . . , ui − 1.
Then for each i = 1, . . . ,m0 we have,
E
(
V
V + S
I {U = ui}
)
≤ E
(
m− ui + 1
m− ui + 1 +Rui
I (U = ui)
)
(B.2)
≤ E
(
m− ui + 1
m− ui + 1 +Rui
I (Pui ≤ γui)
)
(B.3)
=
ui−1∑
r=0
E
(
m− ui + 1
m− ui + 1 + rI (Pui ≤ βr)
∣∣∣∣Rui = r)Pr (Rui = r) (B.4)
The inequality in (B.2) follows due to (5.5). The inequality in (B.3) follows as the
event {U = ui} implies the event {Pui ≤ γui}. (B.4) follows as Rui can take values
between 0 and ui − 1. Then (B.4) becomes,
=
ui−1∑
r=0
m− ui + 1
m− ui + 1 + rPr (Rui = r, Pui ≤ βr)
=
ui−1∑
r=0
m− ui + 1
m− ui + 1 + r [Pr (Rui ≥ r, Pui ≤ βr)− Pr (Rui ≥ r + 1, Pui ≤ βr)]
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≤ Pr (Pui ≤ β0) +
ui−1∑
r=1
m− ui + 1
m− ui + 1 + rPr (Rui ≥ r, βr−1 ≤ Pui ≤ βr)
≤ Pr (Pui ≤ β0) +
ui−1∑
r=1
m− ui + 1
m− ui + 1 + rPr (βr−1 ≤ Pui ≤ βr)
= Pr (Pui ≤ β0) +
ui−1∑
r=1
m− ui + 1
m− ui + 1 + rPr (Pui ≤ βr)
−
ui−2∑
r=0
m− ui + 1
m− ui + 1 + (r + 1)Pr (Pui ≤ βr)
=
ui−2∑
r=0
m− ui + 1
(m− ui + 1 + r)(m− ui + 1 + (r + 1))Pr (Pui ≤ βr)
+
m− ui + 1
m
Pr (Pui ≤ βui−1)
≤ αui
Thus, finally we have,
FDR =
m0∑
i=1
E
(
V
V + S
I {U = ui}
)
≤
m0∑
i=1
αui ≤
m0∑
i=1
α∗ui ≤ α
m∑
i=1
ωi = α.
This shows strong control of FDR under general dependence of the p-values. 
B.2 Proof of (5.18)
To prove (5.18), we separately consider the cases when j ∈ I0 and when j ∈ I1.
Case I: j ∈ I0: In this case, Si = Si−1 and Vi = Vi−1 + 1 when Ji = j. Also,
Vi−1 + Si−1 = i − 1. When i < m, the left hand side of 5.18, after some algebra,
becomes,
E
((
Si−1
i(i− 1) +
(m− j)αSi−1
(m− 1)(i− 1)
2i−m− 1
i(m− i+ 1)
)
I{Ji = j}
)
= E
(
Si−1
(i− 1)(m− i+ 1)
(
(m− i)(m− i+ 1) + α(m− j)(2i−m− 1)
i(m− i)
)
Wi(j − 1)
)
· Pr (Pj ≤ αj)
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≤ E
(
Si−1
(i− 1)(m− i+ 1)
(
m− (α(m− i) + (1− α)(i− 1))
i
)
Wi(j − 1)
)
Pr (Pj ≤ αj)
≤ E
(
α
m− i+ 1
Si−1
i− 1Wi(j − 1)
)
(B.5)
The first equality follows from (5.16) and the fact that both Si−1 and Wi(j − 1) are
only dependent on the first j − 1 hypotheses and hence independent of Pj. The first
inequality follows by noting that m − j ≤ m − i and some algebra. The second
inequality follows as the p-values are stochastically larger than U(0, 1) distribution.
Case II: j ∈ I1: In this case, Si = Si−1 + 1 and Vi = Vi−1 when Ji = j. Also,
Vi−1 + Si−1 = i− 1. Then the left hand side of 5.18, after some algebra, becomes,
E
(( −Vi−1
i(i− 1) +
(m− j)(2i−m− 1)α
i(m− i)(m− i+ 1)
Si−1
i− 1 +
(m− j)α
i(m− i)
)
I{Ji = j}
)
= E
((
Si−1 ((m− i)(m− i+ 1) + α(m− j)(2i−m− 1))
(m− i+ 1)(i− 1)i(m− i) +
(m− j)α− (m− i)
i(m− i)
)
Wi(j − 1)
)
· Pr (Pj ≤ αj)
≤ E
(
Si−1
(i− 1)(m− i+ 1)
(
m− (α(m− i) + (1− α)(i− 1))
i
)
Wi(j − 1)
)
Pr (Pj ≤ αj)
≤ E
(
α
m− i+ 1
Si−1
(i− 1)Wi(j − 1)
)
The first equality follows from (5.16) and by the fact that both Si−1 and Wi(j − 1)
are only dependent on the first j − 1 hypotheses and hence independent of Pj. The
first inequality follows as m−j ≤ m− i. The second inequality follows as the p-values
are stochastically larger than U(0, 1) distribution. 
B.3 Proof of (5.19)
We start from the left hand side of (5.19)
E (fi−1(Ji−1)I{Ji−1 < m+ 1} − fi−1(Ji)I{Ji < m+ 1})
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= E
(
m∑
j=i−1
fi−1(j)I{Ji−1 = j} −
m∑
j=i
fi−1(j)I{Ji = j}
)
= E
(
m∑
j=i
fi−1(j) (I{Ji−1 = j} − I{Ji = j}) + fi−1(i− 1)I{Ji−1 = i− 1}
)
= E
(
m∑
j=i
fi−1(j) (Wi(j)−Wi(j − 1)) + fi−1(i− 1)Wi((i− 1)
)
= E
(
m∑
j=i−1
fi−1(j)Wi(j)−
m∑
j=i
fi−1(j)Wi(j − 1)
)
= E
(
m∑
j=i
(fi−1(j − 1)− fi−1(j))Wi(j − 1)
)
= E
(
m∑
j=i
α
m− i+ 1
Si−1
i− 1Wi(j − 1)
)
The third equality follows from (5.17). The last equality follows from definition of
fi−1(j). 
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